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ARTICLES
THE RETURN OF BIOLOGICAL RACE?
REGULATING INNOVATIONS IN RACE
AND GENETICS THROUGH
ADMINISTRATIVE AGENCY RACE
IMPACT ASSESSMENTS
OSAGIE K. OBASOGIE
I.

*

INTRODUCTION

In April 2011, I published an article in Slate1 that commented on the
new Dietary Guidelines released by the Department of Agriculture and
Department of Health and Human Services.2 These guidelines made several
recommendations with the admirable purpose of encouraging Americans to
take bold steps to improve their health, such as eating smaller portions and
consuming more fruits and vegetables.3 Yet one of the guidelines’ “Key
Recommendations” stood out: “Reduce daily sodium intake to less than
2,300 milligrams (mg) and further reduce intake to 1,500 mg among

* Associate Professor of Law, University of California, Hastings College of the Law with a
joint appointment at the University of California, San Francisco, Department of Social and Behavioral
Sciences; Senior Fellow, Center for Genetics and Society. B.A. 1999, Yale University; J.D. 2002,
Columbia Law School; Ph.D. 2008, University of California, Berkeley. Portions of this Article were
first developed for and appear in a report commissioned by the Center for Genetics and Society entitled
Playing the Gene Card? A Report on Race and Human Biotechnology (2009), and also appear in Osagie
K. Obasogie, Race, Genetics, and the Regulatory Need for Race Impact Assessments, in RACE AND THE
GENETIC REVOLUTION: SCIENCE, MYTH, AND CULTURE (Sheldon Krimsky & Kathleen Sloan eds.
2011); the latter is an edited excerpt of the former. Other short edited excerpts of the report also appear
in Osagie K. Obasogie, Return of the Race Myth, NEW SCIENTIST (July 4, 2009) and Osagie K.
Obasogie, The Color of Our Genes: Balancing the Promise and Risks of Racial Categories in Human
Biotechnology, SCIENCE PROGRESS, June 15, 2009. Marcy Darnovsky, Lisa Eckstein, Lisa Ikemoto,
Richard Hayes, Jonathan Kahn, Kimani Paul-Emile, Dorit Reiss, Jesse Reynolds, Reuel Schiller, Jodi
Short, and Pete Shanks provided invaluable comments on earlier versions of this work.
1.
Osagie K. Obasogie, Black Salt: Should the Government Single Out African-Americans for
Low Sodium Diets?, SLATE (Apr. 18, 2011, 3:07 PM), http://www.slate.com/id/2291513.
2.
See U.S. DEP’T OF AGRIC. & DEP’T OF HEALTH & HUMAN SERVS., DIETARY GUIDELINES
AMERICANS,
2010
(2010),
available
at
FOR
http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/PolicyDoc/PolicyDoc.pdf [hereinafter
DIETARY GUIDELINES FOR AMERICANS].
3.
Id. at viii–xi.
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persons who are 51 and older and those of any age who are African
American or have hypertension, diabetes, or chronic kidney disease.”4
There are certainly prudent medical reasons why older individuals and
those with preexisting conditions should consume less salt.5 But, should
this apply to all Black people? In the Slate article, I examined the scant
support for treating race as a biological risk factor and the overwhelming
evidence suggesting that social determinants of health6—poverty, stress
linked to discrimination, and lack of access to healthy food in urban
environments, among other factors—may better explain Blacks’ higher
rates of hypertension and other sodium-related chronic diseases.7 Although
I expected this perspective to generate pushback in the online comments
section, the Slate article elicited something unusual and unexpected:
interest from a White supremacist website.8 White-Pride.org reposted the
article in its entirety, alongside articles titled Blacks Made Up Majority of
All Serial Killers Last Decade; Obama Spent March Obsessed with
Basketball, Not Learning About Who He Was Bombing; and Obama “Birth
Certificate” Contains Adobe Illustrator Editing Data. It initially seemed
strange to me that a website devoted to news and commentary of this
character would be interested in an article about government
recommendations pertaining to salt intake. But their interest eventually
became clear as some comments implied skepticism toward any claim that
social determinants cause racial disparities. Instead, the comments
suggested that fundamental differences between Whites and minorities
explained Blacks’ poor health outcomes, and these outcomes were simply
an indication of Blacks’ overall inferiority.
A colleague of mine experienced a similar situation. Esteban González
Burchard, a geneticist at the University of California, San Francisco,
4.
Id. at 21 (emphasis added).
5.
See Obasogie, supra note 1. See also Salt: Most Americans Should Consume Less Sodium,
CDC, http://www.cdc.gov/salt (last updated Dec. 21, 2011).
6.
The World Health Organization defines social determinants of health as:
[T]he conditions in which people are born, grow, live, work and age, including the health
system. These circumstances are shaped by the distribution of money, power and resources
at global, national and local levels, which are themselves influenced by policy choices. The
social determinants of health are mostly responsible for health inequities—the unfair and
avoidable differences in health status seen within and between countries.
Social determinants of health, WORLD HEALTH ORG., http://www.who.int/social_determinants/en (last
visited Dec. 2, 2012).
7.
Obasogie, supra note 1.
8.
See WHITE-PRIDE, http://white-pride.org/2011/04/should-the-government-single-out-africanamericans-for-low-sodium-diets (last visited Apr. 20, 2011). This website has since been taken down
and is no longer accessible.
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researches asthma disparities in Latino communities; Puerto Ricans have
the highest asthma prevalence, morbidity, and mortality, while Mexicans
have the lowest.9 Much of Burchard’s research focuses on finding the
genetic differences that may explain these disparities both within and
among racial groups in order to develop treatments to improve minority
health.10 Imagine Burchard’s surprise when he received an e-mail in 2007
from former Louisiana politician—and former Grand Wizard for the Ku
Klux Klan—David Duke,11 commending him for his research:
I do think your work and others who show real biological differences
between races is important. You show that race is truly real, not a societal
construct or some sort of conspiracy theory. As you know, there are about
135 breeds (races) of dogs that are all part of the same species. They can
all interbreed just as the human races can. Who can deny the differences
in appearance, character, and physiology between dog breeds that can
vary as much as the Maltese and the Great Dane? . . . Are we so blinded
by egalitarian dogma that we can’t see the obvious differences in human
races and their expressions in culture? As you are well aware, dog races,
similarly to human races, have diseases that are specific to them.
The truth is, when it comes to human racial differences, we live in a
world in which believing that “there is no such thing as human races” has
become a religion, and those who recognize the realities of human races
have become heretics who are called “racists.”12

Another colleague, Dorothy Roberts, a professor of law and sociology
at the University of Pennsylvania, experienced a similarly strange dynamic
at an April 2006 conference on race-based medicine at the Massachusetts
Institute of Technology.13 Roberts presented a paper on the lack of
9.
Esteban González Burchard et al., Lower Bronchodilator Responsiveness in Puerto Rican
than in Mexican Subjects with Asthma, 169 AM. J. RESPIRATORY & CRITICAL CARE MED. 386 (2004).
10. See e.g., Rajesh Kuman et al., Genetic Ancestry in Lung-Function Predictions, 363 NEW
ENG. J. MED. 321 (2010); Rasika A. Mathias et al., A Genome-Wide Association Study on AfricanAncestry Populations for Asthma, 125 J. ALLERGY & CLINICAL IMMUNOLOGY 336 (2010); Haig
Tcheurekdjian et al., ALOX5AP and LTA4H Polymorphisms Modify Augmentation of Bronchodilator
Responsiveness by Leukotriene Modifiers in Latinos, 126 J. ALLERGY & CLINICAL IMMUNOLOGY 853
(2010).
11. B. Drummond Ayres Jr., Political Briefing; Republicans Decide To Ignore David Duke,
N.Y. TIMES, Apr. 18, 1999, http://www.nytimes.com/1999/04/18/us/political-briefing-republicansdecide-to-ignore-david-duke.html; David Firestone, A Dealing with David Duke Haunts Louisiana
Governor, N.Y. TIMES, June 22, 1999, http://www.nytimes.com/1999/06/22/us/a-dealing-with-davidduke-haunts-louisiana-governor.htm.
12. David Duke, Race & Medicine: A Reply from David Duke, DAVID DUKE (Mar. 10, 2007,
4:52 AM), http://www.davidduke.com/general/race-and-medicine-a-reply-from-david-duke-to-a-quoteof-dr-esteban-burchard_1886.html.
13. Anne Pollock, Medicating Race: Heart Disease and Durable Preoccupations with Difference
(May 1, 2007) (unpublished Ph.D. dissertation, Massachusetts Institute of Technology) (on file with
author); DOROTHY ROBERTS, FATAL INVENTION: HOW SCIENCE, POLITICS, AND BIG BUSINESS RECREATE RACE IN THE TWENTY-FIRST CENTURY 183–85 (2011).
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consensus within the African American community on race-based
medicine, or drugs that claim to be tailored to treat diseases in specific
racial groups.14 Roberts described the diverse viewpoints within the Black
community—from those who were skeptical of treating social categories of
race as biologically-relevant labels to those who believe race-based
medicine is an important step in resolving racial disparities in health. At the
end of the talk, Juan Cofield, President of the NAACP’s New England
Chapter, stood up and vigorously criticized Roberts by shouting, “There is
consensus in the Black community that [BiDil, the first race-based
medication for Blacks with heart failure,] is good for black people.”15 He
then accused Roberts, who has had a celebrated career promoting racial
justice and fighting health care inequalities, as irresponsibly jeopardizing
Black people’s lives and suggested that their blood would be on her
hands.16 Without blinking, Roberts calmly replied: “there isn’t a consensus
[about BiDil] among black people in this room,”17 let alone among all
members of the Black community, as Cofield suggested.
These three situations reflect a growing crisis in lay and scholarly
perspectives on race: a renewed legitimacy in what can be called
“biological race,” or the idea that social categories of race reflect inherent
biological differences that explain racial groups’ disparate social and health
outcomes. Ever since the end of World War II—when the Holocaust
exposed the horrors that ideas about biological race can produce—laws and
social norms sympathetic to the idea that race is a social construction have
fostered egalitarian sentiments. The social constructionist view explicitly
rejects biological race, promoting instead the notion that different outcomes
and abilities between races are linked to the privileges and burdens that
society places on each group.18 This idea has been the intellectual
foundation for advances in civil rights, human rights, and constitutional
law.19 Modern notions of social and legal equality are premised on the
concept that race reflects mere superficial differences and that variations in
human abilities do not fall along racial lines.
But new developments in genetic research are rehabilitating biological
explanations for racial differences and disparities, creating unprecedented
14. ROBERTS, supra note 13, at 184. See also Pollock, supra note 13.
15. Pollock, supra note 13. See also ROBERTS, supra note 13, at 184 (“Juan Cofield stood up in
the audience and emotionally objected. ‘There is consensus supporting BiDil,’ he shouted at me.”).
16. ROBERTS, supra note 13, at 184.
17. Pollock, supra note 13.
18. See infra Part II.G.
19. See infra Part II.G.
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tensions for the regulatory state. For example, race-based medicines
promise drugs that are tailored for optimal use in particular groups,20
genetic ancestry tests claim to offer the ability to determine individuals’
racial and ethnic origins,21 and certain applications of DNA forensics
leverage biological understandings of race to identify criminal suspects.22
Compared to historical discussions on biological race, these new
developments present a dramatic shift in tone. Past claims concerning
biological race were used explicitly to subordinate racial minorities while
current claims are often articulated as efforts to help reduce inequality by,
for example, providing innovative mechanisms to resolve health disparities.
What connects past and present, however, is a persistent belief in racial
typologies, or that social categories of race reflect distinct biological
groupings that are linked to essential traits and behaviors. It is through this
shared thread of typological thinking that past ideas concerning racial
hierarchy and meanings can be preserved in new technologies that may be
facially benign or beneficent.
This tonal shift is significant because the line between discriminatory
and ostensibly beneficial uses of biological race is neither bright nor
intuitive. For example, the aforementioned federal dietary guidelines treat
race as a biological risk factor of the same consequence as advanced age or
having diabetes for the laudable purpose of reducing health disparities in
sodium-related diseases.23 On the other hand, those on White-Pride.org
may embrace the very same biological understanding of racial disparities in
health, but for a different reason: to assert Whites’ inherent superiority.24
Similarly, Burchard’s research looking for genetic variations linked to
asthma is motivated by an attempt to reduce racial disparities, while Duke’s
support of this type of research most likely stems from a White-supremacist
belief that minorities’ health problems are a function of their inferior
physiology. And, although Roberts’s skepticism toward race-based
medicine follows, in part, from a concern that the questionable science
behind this approach might reinvent biological notions of race in a manner
that ultimately disserves minority communities,25 the NAACP and other

20. See infra Part III.A.
21. See infra Part III.B.
22. See infra Part III.B.
23. DIETARY GUIDELINES FOR AMERICANS, supra note 2, at 55.
24. See the discussion of White-Pride.org, supra note 8.
25. ROBERTS, supra note 13, at 185 (“NitroMed did not make money from a drug that was
developed to treat heart failure in black patients. It made money by converting a drug for heart failure
into a drug for African Americans based on unsubstantiated claims about racial difference.”).
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groups claiming to represent the Black community have endorsed racebased medicine as a way to resolve racial disparities in health outcomes.26
These tensions raise a critical legal and regulatory question: given the
extraordinary amount of suffering linked to past government-enforced
notions of biological race—from slavery to eugenics to Tuskegee—how are
we to know when these new articulations further racial subordination or
advance racial justice? This dichotomy draws attention to the remarkable
stakes involved in devising sound regulatory approaches to vet new
innovations premised upon biological understandings of racial difference
and disparities. Overly permissive oversight mechanisms may allow
problematic claims about race and genetics to engender discrimination and
exacerbate racial inequality. On the other hand, excessively strict
regulations may prevent potentially beneficial applications from helping
those most in need. Because the intent behind the development of new
technologies is not dispositive of the actual effect they will have on
minorities or public conceptions of race, a broader assessment of these new
technologies’ impact is needed to inform regulatory decision-making.
This Article proposes race impact assessments as a new regulatory
model for administrative agencies that creates a collaborative and
deliberative space for multiple stakeholders to provide recommendations to
regulators about how to balance the risks and benefits of new technologies
that have the potential to give undue legitimacy to biological race. I draw
upon prior impact assessment work in environmental law and other fields
in which government agencies thoroughly assess new innovations’ broader
impact before going forward. For example, just as an environmental impact
assessment pursuant to the National Environmental Policy Act (“NEPA”)
would look at the many ways a proposed federal highway might affect the
surrounding environment and ecosystems, I similarly argue that proper
regulation of new technologies that implicate race must also engage in a
prospective assessment of their potential impact on racial minorities and
public understandings of race.
By proposing race impact assessments in this Article, I make a critical
departure from mainstream legal and policy discussions on regulating the
use of racial categories in science in at least two ways. First, the scholarly
conversation and regulatory focus regarding developments pertaining to
26. Id. at 184 (“According to [the NAACP’s] view, the urgent crisis of African American heart
disease must take precedence over political objections to the use of race as biomedical category. Indeed,
these objections are seen as a form of racial discrimination or betrayal on grounds that they block black
heart patients’ access to the medicines they need.”).
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race and genetics have disproportionately centered on biomedicines (such
as BiDil) without simultaneously examining how other biotechnologies are
also giving new legitimacy to biological race.27 Genetic ancestry tests that
use a direct-to-consumer model to give individuals information on their
racial and ethnic backgrounds are reinforcing public understandings of race
as a biologically-based, genetic entity that can be known by simply
swabbing one’s cheek and mailing the results to a laboratory. Similarly,
criminal investigators are using biotechnologies that implicate race in
forensic investigations, which can influence public understandings of racial
difference and has a distinct impact on minority communities. For example,
law enforcement officials are using genetic analyses of unknown biological
samples at crime scenes to develop visual depictions of possible suspects.
This can include characteristics such as skin color, eye color, and facial
features that ostensibly point directly to a suspect’s racial appearance.28 By
arguing for race impact assessments that examine regulatory needs in all
three areas—biomedicine, genetic ancestry tests, and DNA forensics—this
proposal is able to assess these technologies’ synergistic effects across
multiple fields and provide a more holistic regulatory mechanism that
balances risks and benefits.
Secondly, a significant and influential thread of the literature on
regulating race-based biotechnologies draws upon constitutional law for a
set of normative rules to govern if, how, and when new applications that
use race as a biological marker of human difference should be made
publically available.29 As a second departure, this Article’s proposed model
does not rely on constitutional law to provide a set of normative rules to
govern these technologies. Rather, I argue that administrative agencies—
the Food and Drug Administration (“FDA”) with regard to race-based
medicine, the Federal Trade Commission (“FTC”) with regard to genetic

27. See, e.g., M. Gregg Bloche, Race-Based Therapeutics, 351 NEW ENG. J. MED. 2035 (2006);
Richard S. Cooper et al., Race and Genomics, 348 NEW ENG. J. MED. 1166 (2003); Carlos Bustamante
et al., Genomics for the World, 475 NATURE 163 (2011).
28. Gautum Naik, To Sketch a Thief: Genes Draw Likeness of Suspects, WALL ST. J., Mar. 27,
2009, at A9.
29. See Jonathan Kahn, Genes, Race, and Population: Avoiding a Collision of Categories, 96
AM. J. PUB. HEALTH 1965 (2006) [hereinafter Kahn, Genes, Race, and Population]; Erik Lillquist &
Charles A. Sullivan, The Law and Genetics of Racial Profiling in Medicine, 39 HARV. C.R.-C.L. L.
REV. 391 (2004); Osagie K. Obasogie, Beyond Best Practices: Strict Scrutiny as a Regulatory Model
for Race-Specific Medicines, 36 J.L. MED. & ETHICS 491 (2008); Kimani Paul-Emile, The Regulation of
Race in Science, 80 GEO. WASH. L. REV. 1115 (2012); Dorothy Roberts, Legal Constraints on the Use
of Race in Biomedical Research: Toward a Social Justice Framework, 34 J.L. MED. & ETHICS 526
(2006); David E. Winickoff & Osagie K. Obasogie, Race Specific Drugs: Regulatory Trends and Public
Policy, 29 TRENDS IN PHARMACOLOGICAL SCI. 277 (2008).
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ancestry tests, and the Federal Bureau of Investigation (“FBI”) with regard
to DNA forensics—should be used as normative spaces to conduct race
impact assessments that collaboratively investigate and discuss the
potential impact these technologies might have for racial minorities and the
idea of race.
This Article proceeds in four additional parts. In Part II, I provide a
brief history of biological race and law’s complicity in promoting racial
typologies. By uncritically accepting scientific claims premised upon
biological race, law has played a central role in promoting this pernicious
way of thinking about human difference. This rich history situates this
Article’s broader claim that state and federal governments’ past
involvement in subordinating racial minorities through legal enforcements
premised upon biological race obligate them to now implement oversight
mechanisms such as race impact assessments to prevent such subordination
from reoccurring. In Part III, I discuss three developments in human
biotechnology that draw upon biological race and may have a particular
impact on racial minorities: race-based medicine, genetic ancestry tests,
and DNA forensics. In that section, I assess the scientific promise and
limitations of these developments and highlight the concerns they raise
with respect to renewing legitimacy in biological race in ways that may be
harmful. In Part IV, I propose race impact assessments as a regulatory
model for administrative agencies to balance these technologies’ potential
risks and benefits. I then conclude with a discussion about why this
proposed model is urgent for the future of racial justice.
II. LAW, SCIENCE, AND BIOLOGICAL RACE: HISTORY AS
CONTEXT
This Section briefly examines the ascension of biological
understandings of racial difference in the United States in the nineteenth
and twentieth centuries, with a particular emphasis on the central role that
law and science played in producing and embedding its significance. This
is far from an exhaustive history; several books have been devoted to
describing the development of racial thought in the West.30 Rather, this
Section is designed to briefly sketch the trajectory of racial thought that has
oriented itself around biology in order to understand the continuities and

30. See, e.g., GEORGE M. FREDRICKSON, THE BLACK IMAGE IN THE WHITE MIND: THE DEBATE
ON AFRO-AMERICAN CHARACTER AND DESTINY, 1817–1914 (1971); WINTHROP D. JORDAN, WHITE
OVER BLACK: AMERICAN ATTITUDES TOWARD THE NEGRO, 1550–1812 (1968) [hereinafter JORDAN,
WHITE OVER BLACK].
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discontinuities between past and current articulations of biological race.
The legal moments attended to in this Section—anti-miscegenation laws,
immigration laws, and eugenics—serve as guideposts for understanding the
unholy alliance between law and science in fostering the growth of
biological race. The main point is that biological understandings of racial
difference emerged at specific historical moments in response to particular
social, economic, and political conditions filtered through scientific
articulations of biological race. These understandings were promoted and
maintained through the force of law to justify racial subordination. Law’s
central role in absorbing, disseminating, and embedding past scientific
justifications for biological race explains why it must now carefully attend
to modern discussions of biological race as a way to atone for its past
complicity in furthering racial injustice.
A. SCIENTIFIC RACISM AND DARWINISM
With regard to American race relations, religious and cultural
differences have framed social categories of race as a reflection of inherent
group differences since England’s earliest contact with people of color in
Africa and the New World in the sixteenth and seventeenth centuries.31
Distinctions between Christians and heathens on the one hand and civilized
and savage peoples on the other gave content to what became increasingly
racialized group distinctions that were thought of as innate differences
driven by inborn abilities and disabilities.32 These perceived lines of
difference served as a basis from which to determine human worth that,
along with various social dynamics and economic needs, led to the
development of racialized slavery in much of the New World and the
American colonies.33
Science has a long history of using quantitative methods to show that
there are measureable physical distinctions between racial groups that
explain differences and disparities in social and health outcomes. The
31. “[T]he English experience was markedly different from that of the Spanish and Portuguese
who for centuries had been in close contact with North Africa and had actually been invaded and
subjected by people both darker and more ‘highly civilized’ than themselves.” WINTHROP JORDAN, THE
WHITE MAN’S BURDEN: HISTORICAL ORIGINS OF RACISM IN THE UNITED STATES 10 (1974)
[hereinafter JORDAN, WHITE MAN’S BURDEN].
32. Id. (“Englishmen and Christians everywhere were sufficiently acquainted with the concept
of heathenism that they confronted its living representatives without puzzlement. Certainly the rather
sudden discovery that the world was teeming with heathen people made for heightened vividness and
urgency in the longstanding problem; but it was the fact this problem was already well formulated long
before contact with Africa which proved important in shaping English reaction to the Negro’s defective
religious condition.”).
33. See generally, JORDAN, WHITE OVER BLACK, supra note 30.

OBASOGIE FINAL V3

10

2/26/2013 1:33 PM

Southern California Interdisciplinary Law Journal

[Vol. 22:1

scientific method was used during the nineteenth century to both
supplement and move away from purely religious or cultural explanations
to frame racial differences and disparities as objectively knowable and
measureable products of nature.34 Instead of merely referencing the Bible
or cultural notions of savagery, science became an increasingly powerful
way to objectively legitimize status-quo racial hierarchies.35
Scholars have documented this practice across many disciplines for
decades. Stephen Jay Gould’s The Mismeasure of Man details the ways in
which biological notions of race were used in the nineteenth century to
sustain racial hierarchies.36 Gould draws attention to how respected
researchers like Samuel Morton, a Philadelphia physician who significantly
influenced early American anthropology, measured the average head size
of various races (the idea being that large heads signify greater cognitive
ability) to establish a ranking system that provided seemingly objective
data to explain and justify White racial dominance.37 Morton’s research
was central to nineteenth-century American polygenesis—the then-popular
theory that each race had separate origins—by legitimating the social order
through measurable scientific claims.38 It is difficult to overstate his impact
on public and scholarly understandings of race at the time. The New York
Tribune wrote as an obituary that “probably no scientific man in America
enjoyed a higher reputation among scholars throughout the world than Dr.
Morton.”39
Morton’s work is by far not the only example of how the scientific
method came to play a prominent role in shaping scholarly and lay

34. See generally, LEE D. BAKER, FROM SAVAGE TO NEGRO: ANTHROPOLOGY AND THE
CONSTRUCTION OF RACE, 1896-1954 (1998).
35. Id.
36. STEPHEN JAY GOULD, THE MISMEASURE OF MAN 83 (1996).
37. Morton amassed a dataset consisting of over six-hundred skulls, mostly from Native
Americans, to show “that a ranking of races could be established objectively by physical characteristics
of the brain, particularly by size.” Id. Gould’s argument that Morton fudged his measurements to fulfill
white supremacist ideologies has recently been reexamined, with the authors arguing, “Morton did not
manipulate data to support his preconceptions.” Jason E. Lewis et al., The Mismeasure of Science:
Stephen Jay Gould versus Samuel George Morton on Skulls and Bias, 9 PLOS BIOLOGY 1 (2011). Upon
reviewing this article by Lewis et al., the editors of Nature concluded that, taken at face value, their
“critique leaves the majority of Gould’s work unscathed” and noted the article’s limitations in that the
authors “couldn’t measure all of [Morton’s] skulls, [meaning that] they do not know whether the
average cranial capacities that Morton reported represent his sample accurately.” The Nature editors
also stated that although Lewis et al. accuse Gould of being driven by certain commitments in his
reassessment of Morton’s data, “Lewis and his colleagues have their own motivations.” Editorial,
Mismeasure for Mismeasure, 474 NATURE 419 (June 23, 2011).
38. GOULD, supra note 36, at 84.
39. Id. at 83.
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understandings of race during this period.40 Science came to play an even
stronger role in conceptualizing racial differences after the 1859
publication of Charles Darwin’s On the Origins of Man. Darwin’s theory is
quite simple: organisms’ traits are hereditary, adapting to environmental
pressures and changing over time to confer survival advantages (evolution)
through natural selection or sexual reproduction.41 Darwin was not the first
to propose an evolutionary model for organisms’ development. His
contribution was to theorize how evolution happens through natural
selection; mating between the strongest and most attractive individuals
provides survival advantages to subsequent generations and improves
organisms’ overall strength and vitality.42
Darwinism helped resolve a virulent debate among race commentators
at the time: whether all humans had one single origin (monogenism) or
whether each race had different and unrelated biological origins
(polygenism).43 Darwinism presented the great compromise that
superseded this theoretical impasse. Evolution by natural selection allowed
monogenists to “win” part of the argument that man has one origin from
which racial hierarchies with superior and inferior races evolved, while
polygenists “won” in that the heritability of differences in ability appeared
to be supported by the idea that great evolutionary distances separated the
races.44 Put bluntly, the racist tendencies underlying each theory led to their
consensus around evolution to the extent that “it provided an even better
rationale for their shared racism.”45
The close connection Darwin drew between human evolution and the
ability to empirically document its different stages fueled a flame of
measuring racial differences that had already been burning since the early
nineteenth century. Scientists like Morton and his successors thought that if
the races represented the stages of human evolution, measuring these
differences would be absolutely crucial to giving these social observations

40. For a thorough examination of the different ways in which scientific measurements were
used to identify racial difference, see THE NATURE OF DIFFERENCE: SCIENCES OF RACE IN THE UNITED
STATES FROM JEFFERSON TO GENOMICS (Evelynn M. Hammonds & Rebecca M. Herzig eds., 2008).
41. See generally CHARLES DARWIN, ON THE ORIGIN OF SPECIES (1859).
42. See Herbert Hovenkamp, Evolutionary Models in Jurisprudence, 64 TEX. L. REV. 645, 651
(1985) (“The theory of natural selection in biology required only the production of numerous organisms
and an environment so impoverished that it could accommodate only a few of them. The organisms
thrown into this predicament were forced to compete, with the result that only a small number survived
and reproduced.”).
43. GOULD, supra note 36, at 105.
44. Id.
45. Id.
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scientific backing.46 Thus, as Thomas Gossett notes, the “nineteenth
century [became] a period of exhaustive and, as it turned out, futile search
for criteria to define and describe race differences.”47
The ascension of measurement as defining proper scientific thought
reified the notion that observing the status quo leads to racial truth
concerning groups’ inherent abilities, which intensified the scrutiny given
to racial bodies that predicated post-Civil War race relations. Racial bodies
and their performances became subject to exacting visual attention as part
of an effort to explain racial minorities’ natural state as degraded and
inferior.48 In post-Civil War America, this type of policing became a new
type of social control. The Civil War and ensuing constitutional
Amendments may have formally liberated Blacks, but science became the
new basis for continuing their social and legal degradation. Blacks’ limited
progress was explained as so natural, normal, and predictable by scientific
observations that even laypeople could appreciate it by simply looking out
into the world.
Indeed, legal historian Ariela Gross notes that after the Civil War, “the
color line replaced the boundary between free and slave, race replaced
slave status, and a regime of whiteness replaced the regime of slavery as
the weapon of oppression.”49 Gross argues that science played a key role in
these transformations in that “it was [during] the post-Civil War period that
racial science triumphed and became the single argument for explaining
‘race.’”50 This is a subtle but important point that deserves attention.
Although the Civil War and Reconstruction Amendments provided
powerful mechanisms to make Blacks full citizens, there were equally
powerful opposing forces determined to maintain racial subordination. The
increasingly sophisticated notion of race-as-biology played this key role:
providing a rational and objectively verifiable measurement system that

46. THOMAS GOSSETT, RACE: THE HISTORY OF AN IDEA IN AMERICA 68–69 (1963).
47. Id. at 69. Gould corroborates this sentiment by noting that the second half of the nineteenth
century was distinguished by:
the allure of numbers, the faith that rigorous measurement could guarantee irrefutable
precision, and might mark the transition between subjective speculation and a true science as
worthy as Newtonian physics. Evolution and quantification formed an unholy
alliance. . . . By the end of Darwin’s century, standardized procedures and a developing
body of statistical knowledge had generated a deluge of more trustworthy numerical data.
GOULD, supra note 36, at 106.
48. See generally, Ariela Gross, Litigating Whiteness: Trials of Racial Determination in the
Nineteenth-Century South, 108 YALE L. J. 109 (1998).
49. Id. at 177.
50. Id.
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demonstrated racial minorities’ inferiority as natural, inherent, and
heritable. Within this warped Darwinian framework, this not only justified
the status quo, but gave moral impetus to the belief that to try to change
these status relationships would be contrary to evolutionary progress and,
thus, society itself.
B. SOCIAL DARWINISM AND EUGENICS
The social sciences became particularly useful in justifying
inequalities “in terms of a natural hierarchy of class and race caused by a
struggle for existence wherein the fittest individuals or races advanced
while the inferior became eclipsed.”51 These popular terms—“the struggle
for existence” or more often “the survival of the fittest”—are often
attributed to Charles Darwin, but actually belong to Herbert Spencer.52
Spencer, an Englishman, had a profound impact on American social
sciences. Although Darwin often balked at directly applying his
evolutionary thought to social relations, Spencer developed his own quasievolutionary theories before Darwinism hit the scene that treated social
organisms the same way Darwin approached biological ones.53 Thus,
Spencer advocated what came to be known as Social Darwinism: “the idea
of natural selection was translated to a struggle between individual
members of society[;] . . . nature’s indispensable method for producing
superior men, superior nations, and superior races.”54 In the context of both
Darwin’s rock-star status in the United States and the postwar need for
rational explanations of human difference, Spencer’s “biological analogy”
was, to put it mildly, the right theory at the right time. The parallels
Spencer made between the natural and social sciences were simply too
elegant and seductive for Americans to resist.55
Race became a key framing for Social Darwinism. For example,
Spencer analogized the evolutionary gap between savage and civilized
minds as being akin to the gulf in cognitive abilities between juveniles and

51. BAKER, supra note 34, at 27.
52. JOSEPH GRAVES, THE EMPEROR’S NEW CLOTHES: BIOLOGICAL THEORIES OF RACE AT THE
MILLENNIUM 75 (2003).
53. HERBERT SPENCER, SOCIAL STATICS: OR, THE CONDITIONS ESSENTIAL TO HUMAN
HAPPINESS SPECIFIED, AND THE FIRST OF THEM DEVELOPED 426 (1851) (“Regarding society as an
organism, . . . it is impossible artificially to use up social vitality for the more active performance of one
function without diminishing the activity with which other functions are performed. So long as society
is let alone, its various organs will go on developing in due subordination to each other.”).
54. GOSSETT, supra note 46, at 145.
55. See id. at 144–75.
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adults.56 Here, as throughout this period, social scientific measurements
merged with Social Darwinist theory to reveal the evolutionary and
biological hierarchies embedded in these race discourses through quantified
comparisons of geographically separated and visually distinguishable
groups.57
With the intellectual and “scientific” basis for conceptualizing and
measuring racial hierarchy establishing itself throughout the nineteenth
century, the question at the turn of the twentieth century became quite
pragmatic: What should be done about it? This context gave rise to the
eugenics movement, which was an international effort to use science and
medicine to justify limiting the reproduction—and existence—of
individuals deemed to be of an inferior racial stock while promoting the
reproduction of those thought to be racially superior.58 Also known as
“racial hygiene,” eugenics came to dominate social, political, and legal
thought in the early twentieth century across America and Western Europe,
leading law and public policy to become complicit in the devastating and
brutal treatment of the most vulnerable populations.59 The incorporation of
scientific understandings of biological race into American law and public
policy during this period can be seen in at least three ways: immigration
restrictions, forced sterilizations, and anti-miscegenation laws.
1. Immigration Restrictions
Immigration was an important aspect of late-nineteenth and earlytwentieth-century eugenics ideology because population control was seen
as central to managing the United States’ racial composition.60 Chinese
laborers were drawn to the West Coast after the Civil War to assist with
railroad construction, mining, and other manual labor.61 At first, Americans
welcomed this cheap and plentiful labor, but soon disparaged it as
economic conditions worsened.62 Anti-Chinese sentiments spurred by

56. Herbert Spencer, The Comparative Psychology of Man, J. ANTHROPOLOGICAL INST. OF GR.
BR. & IR., 301, 303–04 (1876).
57. See GOSSETT, supra note 46, as 144–75.
58. Garland E. Allen, Eugenics and Modern Biology: Critiques of Eugenics, 1910–1945, 75
ANNALS HUM. GENETICS 314 (2011).
59. Id.
60. Ian F. Haney López writes, “The racial composition of the U.S. citizenry reflects in part the
accident of world migration patterns. More than this, however, it reflects the conscious design of U.S.
immigration and naturalization laws.” IAN F. HANEY LÓPEZ, WHITE BY LAW: THE LEGAL
CONSTRUCTION OF RACE 37 (1996).
61. Kitty Calavita, The Paradoxes of Race, Class, Identity, and “Passing”: Enforcing the
Chinese Exclusion Acts, 1882–1910, 25 LAW & SOC. INQUIRY 1, 4 (2000).
62. Id.

OBASOGIE FINAL V3

2012]

2/26/2013 1:33 PM

The Return of Biological Race?

15

organized labor and general social anxieties toward racial otherness led to
an understanding of Chinese individuals as a separate and biologically
different group.63 Much of this anxiety stemmed from the disproportionate
number of Chinese men immigrating: the 1890 Census showed 102,620
Chinese men versus 3868 Chinese women present in the United States.64
This imbalance resulted in a heightened threat of sexual competition
and mixed-race offspring thought to be biologically inferior, leading to
various state and local restrictions on Chinese immigration that eventually
percolated to the federal level.65 For example, an 1877 Congressional
report by the Joint Special Committee to Investigate Chinese Immigration
noted that, “there is not sufficient brain capacity in the Chinese race to
furnish motive power for self-government. Upon the point of morals, there
is no Aryan or European race which is not far superior to the
Chinese . . . .”66 This was followed by a series of Chinese Exclusion Acts
beginning in 1882 that limited Chinese laborers’ ability to enter the United
States. The Supreme Court upheld the constitutionality of these acts in
1889 in Chae Chan Ping v. United States:
The differences of race added greatly to the difficulties of the
situation. . . . It seemed impossible for them to assimilate with our people
or to make any change in their habits or modes of living. As they grew in
numbers each year the people of the coast saw, or believed they saw, in
the facility of immigration, and in the crowded millions of China, where
population presses upon the means of subsistence, great danger that at no
distant day that portion of our country would be overrun by them unless
prompt action was taken to restrict their immigration.67

This sentiment toward Chinese individuals as an unassimilable and
biologically distinct racial group persisted in further legislative acts and
judicial decisions throughout this period. Justice Harlan’s 1896 dissent in
Plessy v. Ferguson, where he advocated colorblindness in questioning the
constitutionality of separate but equal railroad accommodations for Whites
and Blacks, noted that “there is a race so different from our own that we do
not permit those belonging to it to become citizens of the United
States. . . . I allude to the Chinese race.”68 This notion of intractable
difference as a predicate for racial exclusion via immigration policies was
63. See id.
64. Id.
65. Id.
66. Id. (quoting U.S. CONG. JOINT SPECIAL COMM. TO INVESTIGATE CHINESE IMMIGR., S. REP.
NO. 44-689 (1877)).
67. Chae Chan Ping v. United States, 130 U.S. 581, 595 (1889).
68. Plessy v. Ferguson, 163 U.S. 537, 561 (1896) (Harlan, J., dissenting).

OBASOGIE FINAL V3

16

2/26/2013 1:33 PM

Southern California Interdisciplinary Law Journal

[Vol. 22:1

also captured through various aspects of popular culture. For example, in
this advertisement from circa 1900, the message that “they must go”
conflates the product’s pest control abilities with broader political
sentiments concerning biological difference and Chinese exclusion.69
Chinese people are depicted as more rodent-like than human.

Figure 1: Advertisement70
However Chinese people were not the only group targeted for
immigration restrictions. At the same time, White racial purity was
idealized in particular ways. It “favored the ‘Nordics’ of northern and
western Europe over the ‘undesirable races’ of eastern and southern
Europe.”71 The late nineteenth and early twentieth centuries witnessed a
large influx of immigrants from eastern and southern Europe, creating
hysteria similar to that on the West Coast pertaining to Chinese
immigration.72 Many feared that the idealized Nordic bloodstream would
be diluted and overrun by White Europeans of a lesser stock.73 Yale
69. David
Segal,
Uncle
Ben,
CEO?,
SLATE,
Apr.
20,
2007,
http://www.slate.com/articles/arts/culturebox/2007/04/uncle_ben_ceo.html (follow hyperlink to slide
show essay).
70. Id.
71. Mae M. Ngai, The Architecture of Race in American Immigration Law: A Reexamination of
the Immigration Act of 1924, 86 J. AM. HIST. 67, 69 (1999).
72. DANIEL J. KEVLES, IN THE NAME OF EUGENICS: GENETICS AND THE USES OF HUMAN
HEREDITY 96 (1985).
73. Id. at 96–97.
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historian Daniel Kevles notes that, with regard to immigration debates in
Washington in the 1920s, “[o]n both sides of Capitol Hill biological and
racial arguments figured prominently in the floor debate. . . . Congressman
Robert Allen, Democrat of West Virginia, declared: ‘The primary reason
for the restriction of the alien stream . . . is the necessity for purifying and
keeping pure the blood of America.’”74 These discussions led to the
passage of the Immigration Act of 1924,75 which restricted immigration
from Eastern Europe.76 It was signed by President Calvin Coolidge, who
previously as vice president said that “America must be kept American.
Biological laws show . . . that Nordics deteriorate when mixed with other
races.”77
2. Forced Sterilizations
While most people associate the eugenics movement with the horrors
of Nazi Germany, many fail to acknowledge that the world’s first eugenics
sterilization law was implemented in Indiana in 1907 and that the Nazis
looked to American eugenicists for guidance on how to pursue racial
hygiene.78 In fact, forced sterilization laws were extremely popular in the
United States. Between 1907 and 1963, more than 60,000 Americans were
sterilized against their will pursuant to state laws.79 The number of state
laws and compulsory sterilizations accelerated after the 1927 Supreme
Court decision Buck v. Bell,80 where the Court upheld the forced
sterilization of an ostensibly feebleminded Carrie Buck because, as Justice
Oliver Wendell Holmes famously declared, “[i]t is better for all the world,
if instead of waiting to execute degenerate offspring for crime, or to let
them starve for their imbecility, society can prevent those who are
manifestly unfit from continuing their kind. . . . Three generations of
imbeciles are enough.”81
Although compulsory sterilizations affected many groups, from the
disabled to those who were simply poor and without opportunities for selfbetterment, biological notions of race, inferiority, and human difference

74.
75.
76.
77.
78.

Id. at 97.
Immigration Act of 1924, 43 Stat. 153 (repealed 1952).
KEVLES, supra note 72, at 97.
Id.
EDWIN BLACK, WAR AGAINST THE WEAK: EUGENICS AND AMERICA’S CAMPAIGN TO
CREATE A MASTER RACE 280 (2003).
79. Hoangmai H. Pham & Barron H. Lerner, In the Patient’s Best Interest? Revisiting Sexual
Autonomy and Sterilization of the Developmentally Disabled, 175 W. J. MED. 280, 280–81 (2001).
80. Id. at 280.
81. Buck v. Bell, 274 U.S. 200, 207 (1927).
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drove these practices’ ideological implementation.82 The “defects” that
these polices sought to eliminate were thought to be heritable through
reproduction. But even within the broad range of affected groups, racial
minorities disproportionately bore the brunt of these policies. The social
and physical defects sought to be eliminated—such as criminality,
feeblemindedness, and loose sexual morals—were thought to be
disproportionately present among people of color. For example, between
1937 and 1968, federal funds were used to sterilize over 35 percent of
women in Puerto Rico who were in their reproductive years.83 Native
American women were similarly targeted for eugenic sterilization as early
as the 1930s.84 Between the early 1970s and early 1980s, the Indian Health
Services forcibly sterilized 42 percent of all Native American women of
childbearing age.85 Black people have also been disproportionally targeted.
For example, Harriet Washington notes, “When the North Carolina
Eugenic Commission sterilized 8,000 mentally retarded persons throughout
the 1930s, 5,000 were black.”86 Forced sterilization became so routine in
some Southern Black communities that they were commonly referred to as
“Mississippi [a]ppendectom[ies].”87 Therefore, the very biological
characteristics that the State sought to reduce were themselves racialized.

82. See id.
83. Katharine Karse, The Politics of Women’s Health: Sterilization Abuse, WOMEN’S HEALTH
ACTIVIST
(Nat’l
Women’s
Health
Network),
Jan.–Feb.
1996,
available
at
http://www.ourbodiesourselves.org/book/companion.asp?id=31&compID=55. Angela Hooton puts
Latina women’s experience with forced sterilization in a broader context:
Thousands of Latinas, specifically Puerto Rican, Dominican and Mexican-American
women, suffered from forced or coercive sterilization from the 1950s until the late 1970s.
Many of these women were sterilized in public hospitals immediately following childbirth.
Evidence indicates that some women were not aware that the procedure was happening or
that it would be permanent. For example, one of the most egregious sterilization practices
occurred at the Los Angeles County Medical Hospital, where Mexican-origin women were
sterilized during or immediately following childbirth, without adequate information or
necessary translation.
Angela Hooton, A Broader Vision of the Reproductive Rights Movement: Fusing Mainstream and
Latina Feminism, 13 AM. U. J. GENDER SOC. POL’Y & L. 59, 70–71 (2005) (internal citations omitted).
84. Lindsay Glauner, Comment, The Need for Accountability and Reparation: 1830–1976 the
Unites States Government’s Role in the Promotion, Implementation, and Execution of the Crime of
Genocide Against Native Americans, 51 DEPAUL L. REV. 911, 939 (2002).
85. Id. See also Jane Lawrence, The Indian Health Service and the Sterilization of Native
American Women, 24 AM. INDIAN Q. 400 (2000).
86. HARRIET A. WASHINGTON, MEDICAL APARTHEID: THE DARK HISTORY OF MEDICAL
EXPERIMENTATION ON BLACK AMERICANS FROM COLONIAL TIMES TO THE PRESENT 203 (2006).
87. Id. at 204.
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3. Anti-Miscegenation Laws
Attempts to legally restrict interracial marriage, sex, and reproduction
date back to the seventeenth century, with the first anti-miscegenation
statute legislated in Maryland in 1661. Virginia followed suit in 1662.88
While opposition to interracial sex and marriage had some theological
influences,89 notions of biological race and the desire to prevent the
degradation of White racial purity were present from the very beginning.
For example, a 1691 Virginia statute banished Whites who married
interracially with Blacks, American Indians, or those of a mixed race “for
[the] prevention of that abominable mixture and spurious issue.”90 Keith E.
Sealing notes that up until 1967, when anti-miscegenation laws were held
unconstitutional in Loving v. Virginia,91 they were justified by themes
resonating back to the colonial times, regardless of their basis in science or
religion:
First, there is a natural hierarchy of all beings in the universe. Second,
humans are part of this chain. Third, “race” is a valid concept. Fourth, the
races can be ranked hierarchally: Whites are the superior race,
Asians/Indians are second, and Blacks last. Fifth, this ranking of the races
is immutable. Sixth, miscegenation, the crossing of the races, produces
crosses that are inferior to either parent. Seventh, mixed races have lower
fertility. Eighth, mixing of the races brings the better down to the level of
the lower, rather than improving the lower.92

The eugenics movement brought renewed interest in government
regulation of reproduction through marriage; “by 1914, some thirty states
had enacted new marriage laws or amended old ones.”93 This coincided
with the fact that “[e]very state whose [B]lack population reached or
exceeded 5 percent of the total eventually drafted and enacted antimiscegenation laws.”94 Eugenicists often played a significant role in
passing anti-miscegenation laws during this period in that “they were part
88. RACHEL F. MORAN, INTERRACIAL INTIMACY: THE REGULATION OF RACE AND ROMANCE 19
(2001).
89. The scriptural basis for Blacks’ state of inferiority and servitude stems from the story of
Noah cursing Ham for seeing him naked while drunk. See Genesis 9:20–27.
90. A. Leon Higginbotham, Jr. & Barbara K. Kopytoff, Racial Purity and Interracial Sex in the
Law of Colonial and Antebellum Virginia, 77 GEO. L.J. 1967, 1995 (1989) (quoting Act SVII entitled
“An Act for Suppressing Outlying Slaves” from THE STATUTES AT LARGE; BEING A COLLECTION OF
ALL THE LAWS OF VIRGINIA, VOL. III, 86–87 (1823)).
91. Loving v. Virginia, 388 U.S. 1 (1967).
92. Keith E. Sealing, Blood Will Tell: Scientific Racism and the Legal Prohibitions Against
Miscegenation, 5 MICH. J. RACE & L. 559, 560–65 (2000).
93. KEVLES, supra note 72, at 99.
94. RANDALL KENNEDY, INTERRACIAL INTIMACIES: SEX, MARRIAGE, IDENTITY, AND ADOPTION
219 (2003).
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of a coalition that put the laws on the books, and they provided prior (or, at
times, post hoc) biological rationalizations for what other interest groups
wanted.”95
C. CONCEPTIONS OF RACE AFTER WORLD WAR II
It is largely believed that biological understandings of race completely
disappeared after the end of World War II in 1945, as the consequences of
eugenic policies’ most horrific implementation—the Holocaust—were
fully revealed to the world. However, certain eugenic practices, such as
state-level forced sterilization, did not end until the 1970s.96 The 1950
United Nations Educational, Scientific and Cultural Organization
(“UNESCO”) Statement on Race is often referenced as the proverbial
obituary for biological race. In this document, a group of esteemed
scientists declared:
The biological fact of race and the myth of “race” should be
distinguished. For all practical purposes “race” is not so much a biological
phenomenon as a social myth. The myth of “race” has created an
enormous amount of human and social damage. . . . It still prevents the
normal development of millions of human beings and deprives
civilization of the effective co-operation of productive minds. The
biological differences between ethnic groups should be disregarded from
the standpoint of social acceptance and social action.97

Not all scientists agreed with this bold statement about the biological
irrelevance of race,98 and that pushback was incorporated into subsequent
UNESCO statements.99 Nevertheless, the scientific community’s overall
sentiment at the time was that the old, crude biological understanding of
race was no longer accepted. Or, as the New York Times proclaimed when

95. KEVLES, supra note 72, at 100.
96. For example, North Carolina continued its forced sterilization program until the 1974. NC
DEP’T
ADMIN.,
Justice
for
Sterilization
Victims
Foundation,
N.C.
http://www.sterilizationvictims.nc.gov (last visited Dec. 2, 2012).
97. Statement by Experts on Race Problems, UNESCO Doc. SS/1, at 3–4 (July 20, 1950),
available at http://unesdoc.unesco.org/images/0012/001269/126969eb.pdf.
98. JENNY REARDON, RACE TO THE FINISH: IDENTITY AND GOVERNANCE IN AN AGE OF
GENOMICS 29 (2005).
99. Id. at 30–31. Reardon writes:
Following its publication on 18 July 1950, the First UNESCO Statement on Race received
heavy criticism, especially from physical anthropologists and geneticists. For many of these
scientists, the critical problem with the First UNESCO Statement was that while it advocated
giving scientists a greater role in defining race in society, ironically it limited their ability to
define race in their own research.
Id. at 29 (internal citations omitted).
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reporting on the UNESCO statement’s release in 1950: “No Scientific
Basis for Race Bias Found by World Panel of Experts.”100
In addition to marking the end of the widespread recognition of
biological race, the UNESCO statement is also seen as the moment where
the social-constructionist view on race became widely accepted. This
perspective views race as a social, political, and legal fabrication rather
than a fixed biological fact. While scholars such as Franz Boas argued
against biological race decades before the end of World War II,101 many
people point to the UNESCO Statement and its surrounding discourse as
the intellectual tipping point whereby social constructionism became the
dominant perspective. For example, in his history of scientific racism,
Elazar Barkan, a professor of international and public affairs at Columbia
University, writes that with the 1950s UNESCO Statement, “[t]he reversal
in the scientific credo on [biological] race since the early 1920s had been
completed.”102
During this postwar period, most scientists stopped talking about races
in favor of populations. Population genetics is widely interpreted as
representing a crucial scientific turn away from examining qualitative or
typological categories of difference and toward measuring quantitative
differences in the distribution and frequency of genetic variations among
and between certain groups.103 Rather than focusing on categorizing people
by phenotype, population genetics is thought to have put scientific racism
in the past by focusing its attention on the genotypes of various
populations.104 But, a number of scholars question this interpretation.
Instead of marking a clear move in an anti-racist direction,105 they argue
100. No Scientific Basis for Race Bias Found by World Panel of Experts, N.Y. TIMES, July 18,
1950, at 1.
101. See REARDON, supra note 98, at 90.
102. ELAZAR BARKAN, THE RETREAT OF SCIENTIFIC RACISM: CHANGING CONCEPTS OF RACE IN
BRITAIN AND THE UNITED STATES BETWEEN THE WORLD WARS 341 (1992).
103. REARDON, supra note 98, at 32–33. “[H]istorians of race and science draw upon five
dichotomies to distinguish an ideological typological approach from a scientifically sound population
approach: race/population; race/culture; classificatory/empirical; history/natural selection;
phenotype/genotype.” Id. at 33.
104. Id.
105. In describing the anti-racism that is often presumed to have been ushered in with a
population focus, Lisa Gannett, Associate Professor of Philosophy at Saint Mary’s University, writes:
“Population thinkers” are considered to be averse to the imposition of artificial and arbitrary
“typologies” on heterogeneous biological nature. For this reason, they are supposed to be
open to recognizing the . . . empirical evidence that genetic variability is distributed
statistically across the species, and thus the invalidation of classification schemes that
attempt to categorize each and every human being as belonging to a discrete racial kind or
“type” that is homogeneous for certain characteristics. “Population thinkers” appreciate that
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that the shift in the life sciences from “race” to “population” is ambiguous
and that typological approaches to human difference continue to influence
population approaches to race and genetics.106 As University of California,
Santa Cruz, sociologist Jenny Reardon concludes in her historical account
of this period and its reverberating effects on modern race and genetics
research agendas:
[N]o consensus about the role of race in studying human origins and
diversity emerged following World War II. Physical anthropologists and
geneticists did not all agree—contrary to prevalent historical opinion—
that race had no biological meaning, and should be replaced by a study of
populations. Not even did all agree that typologies had no use in science.
Rather, most sought to redefine scientific ideas and practices for studying
race (including typologies) in the wake of what many perceived as the
abuse of these ideas and practices by eugenicists, segregationists, and the
Nazis.107

This lack of actual agreement in the life sciences concerning the
biological significance of race (in the face of assumed consensus in
virtually all other fields) sets the stage for understanding its continuing
significance in the twenty-first century. The point is not to frame the postWorld War II period as an overly broad dichotomy between public
articulations that race is biologically insignificant and ongoing research
specifically premised on the idea that race reflects inherent and heritable
differences. Rather, it is simply to note that the standard narrative that
biological race disappeared after World War II is at best incomplete and, at
worst, deceptive in that it can obscure connections between past and
present racial typologies in science. In particular, this dichotomy highlights
the perfidious relationship between race and science in contemporary
research and why continued discussion and oversight of this issue is
needed. With this understanding of biological race and its contested
intellectual history, we can now examine new developments in race and
genetics to think through their points of convergence and divergence with
past discussions on biological race.

two individuals from different groups can be genetically more similar than two individuals
from the same group because of the extent to which allele frequency distributions in
populations are overlapping.
Lisa Gannett, Racism and Human Genome Diversity Research: The Ethical Limits of “Population
Thinking”, 68 PHIL. SCI. S479, S489 (2001).
106. Id. at S488–89 (internal citation omitted).
107. REARDON, supra note 98, at 42.
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III. BIOLOGICAL RACE IN THE TWENTY-FIRST CENTURY
Developments in human biotechnology across the past decade have
renewed claims that social categories of race reflect inherent biological
differences that explain disparities in social and health outcomes. This
Section assesses three of these new technologies: race-based medicine,
genetic ancestry tests, and certain aspects of DNA forensics. While each of
these applications developed separately, they are united by a shared effort
that reinvigorates the racial typologies thought to be dismissed in the
1950s: that racial differences are real, meaningful, and measureable at the
molecular level. This Section examines the claims made by each
technology, their supporting science, and the concerns raised in order to
better understand the potential risks and benefits associated with
rearticulating biological race in these new terms.
A. RACE-BASED MEDICINE
1. Claims Made
Race-based medicine hit the scene in 2005, when BiDil became the
first drug to receive FDA approval to treat a specific racial group: African
Americans suffering from congestive heart failure.108 Congestive heart
failure affects the heart’s ability to efficiently pump blood throughout the
body and is caused largely by deteriorating heart muscle.109 Although
millions of Americans suffer from this condition,110 BiDil’s FDA approval
was largely driven by data demonstrating that Blacks are twice as likely to
suffer from heart failure as Whites.111 NitroMed,112 the company that
originally developed BiDil, used this claim throughout the regulatory
process to imply that biological mechanisms led Blacks to have a different
experience with the disease and to justify the unprecedented regulatory
move to label this new drug for a specific race.113

108. Jonathan Kahn, Race in a Bottle, SCI. AM., Aug. 2007, at 40 [hereinafter Kahn, Race in a
Bottle].
109. Id.
110. “[A]n estimated 5,700,000 Americans ≥20 years of age have [heart failure].” Véronique L.
Roger et al., Heart Disease and Stroke Statistics—2012 Update: A Report Filed From the American
Heart Association, CIRCULATION, Jan. 3/10, 2012, at e2, e102, available at
http://circ.ahajournals.org/content/125/1/e2.
111. Jonathan Kahn, Getting the Numbers Right: Statistical Mischief and Racial Profiling in
Heart Failure Research, 46 PERSP. BIOL. & MED. 472, 474 (2003) [hereinafter Kahn, Getting the
Numbers Right].
112. Deerfield Capital acquired NitroMed, a Massachusetts-based biotechnology firm, in 2009
for approximately $36 million. Deerfield Wins NitroMed with Sweetened Offer, DEALBOOK, Feb. 2,
2009, http://dealbook.nytimes.com/2009/02/02/deerfield-wins-nitromed-with-sweetened-offer.
113. Kahn, Race in a Bottle, supra note 108, at 44.
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The story behind BiDil’s clinical development is important for
understanding how and when this groundbreaking claim of race specificity
became relevant. BiDil combines two standard therapies to treat heart
failure—hydralazine and isosorbide dinitrate—into one pill.114 These
generics have been used for decades across all races to treat heart failure.115
BiDil began with two clinical trials in the 1980s: V-HeFT I and V-HeFT
II.116 The V-HeFT I trial lasted from 1980 to 1985 and found that patients
who received the hydralazine/isosorbide dinitrate (“H/I”) combination
therapy had lower mortality outcomes.117 V-HeFT II, lasting from 1986 to
1989, compared this same combination therapy to an ACE inhibitor118
called enalapril. The trial showed that H/I was more effective.119 However,
it is important to keep in mind that “[t]he V-HeFT investigators did not
build the trials around race or ethnicity. They enrolled both Black and
White patients and in the published reports of the trials’ successes, they did
not break down the data by race. Rather, they presented H/I (the BiDil
drugs) as generally efficacious in the population at large, without regard to
race.”120
In 1989 Dr. Jay Cohn, who led the two V-HeFT studies, received a
patent on the method of administering the H/I combination therapy to treat
heart failure, without reference to race.121 Cohn then licensed the drug to
Medco Research, a biotechnology company that then manufactured the
components into one pill that became BiDil.122 The FDA rejected BiDil’s
approval in 1997, noting problems with the statistical design of the V-

114. Id. at 40.
115. Id.
116. Id. at 41.
117. Jay N. Cohn et al., Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart
Failure, 314 NEW ENG. J. MED. 1547, 1551 (1986).
118. Commonly called “ACE inhibitors,” angiotensin-converting enzyme inhibitors “help relax
blood vessels” and are used to “treat a variety of conditions,” including heart failure. AngiotensinConverting Enzyme (ACE) Inhibitors, MAYO CLINIC, http://www.mayoclinic.com/health/aceinhibitors/HI00060 (last updated Dec. 16, 2010).
119. Jay Cohn et al., A Comparison of Enalapril with Hydralazine-Isosorbide Dinitrate in the
Treatment of Chronic Congestive Heart Failure, 325 NEW ENG. J. MED. 303, 307 (1991).
120. Jonathan Kahn, From Disparity to Difference: How Race-Specific Medicines May
Undermine Policies to Address Inequalities in Health Care, 15 S. CAL. INTERDISC. L.J. 105, 109 (2005)
[hereinafter Kahn, From Disparity to Difference].
121. See Kahn, Race in a Bottle, supra note 108, at 42.
122. Id. For a more detailed description of these events, see Jonathan Kahn, How a Drug
Becomes “Ethnic”: Law, Commerce, and the Production of Racial Categories in Medicine, 4 YALE J.
HEALTH POL’Y L. ETHICS 1 (2004).
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HeFT trials.123 Cohn then went back to the V-HeFT data and found that
African Americans gained a particular benefit from the combination
therapy.124 He then filed for and was granted a patent identical to the first
one, except that the use was now for African Americans suffering from
heart failure, which had the financial and commercial benefit of extending
his patent rights an additional thirteen years.125 Cohn licensed BiDil to
NitroMed, who conducted a clinical trial—the African American Heart
Failure Trial (“A-HeFT”)—to test BiDil’s race-specific benefit.126 The AHeFT trial only included participants that self-identified as African
American.127 The trial yielded data demonstrating a 43 percent reduction in
mortality, leading the FDA to approve a race-specific indication for use by
Blacks with heart failure.128
BiDil’s clinical trial design, results, and subsequent FDA approval
supports at least three different claims about the biological significance of
race in relation to racial disparities in disease progression and health
outcomes. Because BiDil is the first drug to be (1) patented as racespecific, (2) approved by the FDA as race-specific, and (3) marketed as
race-specific, it has come to reflect the legal, regulatory, and economic
sanctioning of race as a biologically significant category of human
difference that meaningfully affects human health. Through this framing,
social categories of race appear to be significant markers for otherwise
hard-to-detect biological differences in human populations. Neither Cohn
nor any of his collaborators have been able to identify the biological
markers responsible for Blacks’ receptiveness to BiDil.129 But this lack of
specificity seemed to be of little consequence for regulators, who embraced
the typological sensibilities embedded in biological understandings of race.
They assumed that self-identified race mirrored some underlying “real”
biological difference that shapes health disparities and drug reaction.130 For
example, the chair of the FDA Cardiovascular and Renal Drugs Advisory

123. Kahn, Race in a Bottle, supra note 108, at 42 (noting that the trials were “designed not to
meet the regulatory standards for FDA approval but to test the hypothesis that vasodilators could treat
heart failure”).
124. Id.
125. Id. at 42–43.
126. Id. at 42.
127. Id.
128. Id.
129. In fact, Cohn has said that he prescribes BiDil to some of his White patients, noting, “I
actually think everybody should be using it.” Denise Gellene, Heart Pill Intended Only For Blacks
Sparks Debate, L.A. TIMES, June 16, 2005, http://articles.latimes.com/2005/jun/16/business/fi-bidil16.
130. BiDil African-American Subset is Surrogate for Genomics, Cmte Chair Says, 67 THE PINK
SHEET 3, 3 (2005).
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Committee, which endorsed BiDil’s approval, noted that the committee
treated self-identified race in the A-HeFT trial as “a surrogate for genomic
based medicine,”131 although no genetic data was presented to the
committee.132
2. The Science Behind Race-Based Medicine
Although BiDil’s clinical trials did not identify the genetic variations
that produce racial disparities in heart failure mortality or those that lead
BiDil to work better in Black populations, the drug was nonetheless
heralded as the first in a long line of ostensibly forthcoming personalized
medicines.133 Truly personalized medicines are the province of the
emerging field of pharmacogenomics, which studies how individual genetic
variations might affect persons with a particular genetic makeup.134
Individuals’ genetic sequences contain strings of nucleic acids (Adenine,
Thymine, Cytosine, and Guanine) that may be similar for several hundred
bases.135 They will differ at about one in every 1200 bases;136 one person
might have, for example, Thymine at a particular location instead of
Cytosine. These genetic variations are known as alleles, and an individual’s
collection of alleles or genetic variations make up their genotype.137
Understanding the location and effects of these genetic variations is
important because they can affect drug toxicity, predict the efficacy of
certain therapies, and identify useful drug targets.138
Patient-specific treatments have not developed as quickly as
researchers and academics anticipated. It is in this context that researchers
have tried to develop genetically tailored medications at a further level of

131. Id.
132. See id.
133. For example, the New York Times began their story about the FDA’s approval of BiDil by
noting, “The Food and Drug Administration took a controversial step toward a new frontier of
personalized medicine yesterday, approving the first drug ever intended for one racial group, AfricanAmericans.” Stephanie Saul, F.D.A. Approves a Heart Drug for African-Americans, N.Y. TIMES, June
24, 2005, at C2.
134. William E. Evans & Mary V. Relling, Moving Towards Individualized Medicine With
Pharmacogenomics, 429 NATURE 464 (2004).
135. See The New Genetics: Chapter 1: How Genes Work, NAT’L INST. GEN. MED.SCI.,
http://publications.nigms.nih.gov/thenewgenetics/chapter1.html (last reviewed June 9, 2011).
HAPMAP
PROJECT,
136. What
Is
The
HapMap?,
INTERNATIONAL
http://hapmap.ncbi.nlm.nih.gov/whatishapmap.html.
137. See
Genotype:
Talking
Glossary
of
Genetic
Terms,
GENOME.GOV,
https://www.genome.gov/Glossary/index.cfm?id=93 (last visited Dec. 2, 2012).
138. “One of the most promising areas of genomic medicine is the ability to match an
individual’s genetic profile to the likely effect of particular drugs.” Kathy L. Hudson, Genomics, Health
Care, and Society, 365 NEW ENG. J. MED. 1033, 1036 (2011).
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abstraction to target specific populations instead of individuals.139
Population geneticists’ ability to identify the sets of alleles that tend to be
inherited together in specific groups identifiable by social categories of
race is merging with pharmacogenomicists’ interest in determining the
alleles that affect drug efficacy and response. This gives biomedicine the
presumed ability to use race as a proxy for population-specific variants that
might identify which groups respond best to certain medications or genetic
interventions.
3. Risks and Benefits of Race-Based Medicines
Racial disparities in health are real and persistent.140 As such, racebased medicine provides one potential avenue to resolve these disparities
when other efforts simply are not able to address the problem. This partly
explains why many groups claiming to represent the African American
community were excited by BiDil’s FDA approval, including the NAACP
and the Association of Black Cardiologists.141
But with such strong claims about the biological significance of race,
it is important to look closely at BiDil as a case study on the questionable
premises underlying race-based medicine. First, the moral impetus
justifying a race-specific approach to resolving heart failure—the
commonly cited 2:1 disparity in heart failure outcomes between Blacks and
Whites—is simply inaccurate. For example, NitroMed announced in a 2001
press release that it had received a letter from the FDA affirming BiDil’s
ability to be approved as a new race-specific drug.142 The release said that
“death rates from heart failure are more than twice as high in black patients
than in white patients” and speculated that this disparity may be caused by
“a pathophysiology found primarily in black patients that may involve
nitric oxide (NO) insufficiency.”143 This disparity, and NitroMed’s
speculation concerning its biological underpinnings, were then repeated in
various media outlets.144
139. See, e.g., Esteban Burchard et al., The Importance of Race and Ethnic Background in
Biomedical Research and Clinical Practice, 348 NEW ENG. J. MED. 1170 (2003).
140. See Addressing Racial and Ethnic Disparities in Health Care Fact Sheet, U.S. DEP’T FOR
HEALTH
&
HUM.
SERVS.
AGENCY
FOR
HEALTHCARE
RES.
&
QUALITY,
http://www.ahrq.gov/research/disparit.htm (last visited Dec. 2, 2012).
141. Juan Cofield, President of the New England Area NAACP chapter, has publically stated “I
would like to see the name BiDil as common in our community as Viagra is in the general public.” Dan
Devine, NAACP Goes to the Grassroots for BiDil, BAY ST. BANNER (Oct. 5, 2006),
http://www.baystate-banner.com/archives/stories/2006/10/100506-07.htm.
142. Kahn, Getting the Numbers Right, supra note 111, at 474.
143. Id. (quoting the 2001 NitroMed press release).
144. Id. at 475 (surveying various publications that had reprinted the 2:1 ratio).
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But, a closer look at the data suggests that there is no significant racial
disparity in heart failure outcomes. In fact, the 2:1 number comes from a
string of misquotes referencing decades-old data.145 In 1998 the CDC
placed the ratio at 1.1:1, which essentially means that there is no racial
difference in outcomes.146 NitroMed later revised its claim to say, “The
African-American community is affected at a greater rate by heart failure
than that of the corresponding Caucasian population. African Americans
between the ages of 45 and 64 are 2.5 times more likely to die from heart
failure than Caucasians in the same age range.”147 Though this is accurate,
“[t]he age group 45 to 64 only accounts for about 6% of heart failure
mortality, and for those over 65, the statistical differences between ‘African
Americans and Caucasians’ nearly completely disappear.”148 These
findings significantly undermine the moral justification for a race-specific
approach.
Second, the design of the A-HeFT clinical trial used to demonstrate
BiDil’s race specific impact was flawed. By only enrolling patients that
self-identified as African American without any comparison group, the
clinical trial, by definition, cannot speak to whether the drug works better
in one group than another. As law professor Jonathan Kahn notes, “[t]he
only responsible scientific claim that can be made on the basis of these
trials is that BiDil works in some people who have heart failure, period.”149
The FDA has vigorously defended its decision to approve BiDil’s racespecific labeling and the evidence from A-HeFT used to justify this
decision.150 Scientists for the FDA said that conducting a separate trial to
specifically compare outcomes between Blacks and Whites “would have
required years of work, many thousands of patients, and wholly
unreasonable delay in approval of a treatment whose effectiveness had
145. Id. at 475–78.
146. Changes in Mortality from Heart Failure—United States, 1980–1995, MMWR, Aug. 7,
1998, at 633-37. See also Kahn, Getting the Numbers Right, supra note 111, at 473–74.
147. Press Release, NitroMed, Inc., BiDil(R) Named to American Heart Association’s 2004 ‘Top
10 Advances’ List (Jan. 11, 2005), available at http://www.prnewswire.com/news-releases/bidilrnamed-to-american-heart-associations-2004-top-10-advances-list-54001632.html.
148. Troy Duster, Race and Reification in Science, 307 SCIENCE 1050, 1050 (2005).
149. Kahn, From Disparity to Difference, supra note 120, at 106.
150. Two FDA scientists, Robert Temple and Norman Stockbridge, wrote in the Annals of
Internal Medicine:
Approval of BiDil was not based on a single trial where all data came from the black patient
population, as has been suggested. The FDA’s encouragement of A-HeFT, a singlepopulation trial, arose from recognition that a larger study of black and white patients was
not likely to yield any additional useful information.
Robert Temple & Norman L. Stockbridge, BiDil for Heart Failure in Black Patients: The U.S. Food
and Drug Administration Perspective, 146 ANNALS INTERNAL MED. 57, 58 (2007).
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been well-documented in the group for which it was intended.”151
However, this defense only further highlights the FDA’s assumptions
regarding the biological significance of race when such drug approval
determinations should be based on stronger and more direct evidence.
Third, the assumption that social categories of race can be used as a
proxy for significant genetic variation at the population level is flawed. The
connection between social categories of race and population differences is
unfounded. There are certainly genetic differences between population
groups as a result of various dynamics (such as migration and reproduction)
that may lead certain markers to appear more often in particular groups.
But it is a large leap to suggest that these population dynamics
meaningfully align with social categories of race, especially when the
meaning and salience of these categories stem from social, political, and
economic factors. Francis Collins, former director of the National Institutes
of Health, argues:
“Race” and “ethnicity” are poorly defined terms that serve as flawed
surrogates for multiple environmental and genetic factors in disease
causation, including ancestral geographic origins, socioeconomic status,
education and access to health care. Research must move beyond these
weak and imperfect proxy relationships to define the more proximate
factors that influence health.152

The concerns associated with BiDil’s FDA approval highlight three
broader issues raised by race-based medicines that may belie the effort to
reduce health disparities. First, the emphasis placed on reducing health
disparities through genetic interventions can obscure known social
determinants of health outcomes. A substantial body of evidence has shown
that “[f]actors such as income and education, and how they play out in
housing and neighborhood, directly exert a powerful influence on health
disparities in the United States—potentially as powerful as medical care or
genetics.”153 High profile cases such as BiDil draw substantial attention
and many dollars toward speculating about the possible genetic causes of
health disparities when those resources could be better allocated to address
known social factors that can be improved to reduce gaps in health
outcomes.

151. Id. at 57.
152. Francis S Collins, What We Do and Don’t Know About ‘Race,’ ‘Ethnicity,’ Genetics and
Health at the Dawn of the Genomic Era, 36 NATURE GENETICS SUPP. S13, S13 (2004).
153. ROBERT WOOD JOHNSON FOUND., OVERCOMING OBSTACLES TO HEALTH: STORIES, FACTS
AND FINDINGS 3 (2008), available at http://www.commissiononhealth.org/PDF/ObstaclesToHealthHighlights.pdf.
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This leads to the second concern that continued speculation
concerning the biological roots of racial disparities in health may shift
responsibility for remediation from sustained public health initiatives to
private biomedical ventures. As demonstrated by BiDil’s transformation
from a race-neutral to a race-specific drug, commercial incentives can lead
to premature and unsubstantiated articulations of biological race, which go
against the public interest. Third, weak claims about the biological
relevance of racial disparities in health can prematurely legitimize
biological explanations of racial disparities in other areas such as aptitude
and criminality, which ultimately disserve minority communities.
B. GENETIC ANCESTRY TESTS
1. Claims Made
Genetic ancestry tests are part of a growing field of what some
academics have called “recreational genetics,” where individuals use
direct-to-consumer genetic tests to learn about their genetic predispositions
without direct interactions with medical professionals.154 Some of these
tests are health-related, but a growing number are recreational in the most
literal sense. For example, Atlas Sports Genetics offers a test that allows
parents to determine the sports in which their child might be genetically
predisposed to excel.155 Genetic ancestry tests have developed within this
burgeoning market to give individuals a better sense of their racial and
ethnic heritage.156 Companies that provide this service have amassed
databases containing genetic information from indigenous populations
around the globe and compare individuals’ genetic markers to these
reference populations in order to find similarities that suggest an ancestral
link.157
Genetic ancestry companies often make fantastic claims about their
ability to precisely link consumers’ genes to past ancestors in a manner that
provides robust insight into their identity and heritage.158 These claims

154. Deborah A. Bolnick et al., The Science and Business of Genetic Ancestry Testing, 318 SCI.
399, 399 (2007).
155. Juliet Macur, Born to Run? Little Ones Get Tested for Sports Gene, N.Y. TIMES, Nov. 30,
2008, http://www.nytimes.com/2008/11/30/sports/30genetics.html. This test “is done by swabbing the
inside of the child’s cheek to obtain a DNA sample that is then returned to a lab for analysis for
ACTN3, one of the more than 20,000 genes that make up the human genome. A 2003 study linked
ACNT3 to athletic performance.” Id. See also What is ACTN Sports Gene?, ATLAS SPORTS GENETICS,
http://www.atlasgene.com (last visited Dec. 2, 2012).
156. Bolnick et al., supra note 154, at 399.
157. Id.
158. E.g., The Story Behind Your Y-DNA (Male Ancestry), DNA WORLDWIDE,
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have led nearly half-a-million people to purchase these tests since 2002.159
Moreover, these tests have been used for a variety of purposes beyond pure
recreation. For example, individuals who otherwise identify as White have
used these tests to show that they have some meaningful amount of shared
genetic ancestry with a minority group in order to increase their chances of
being admitted to a university under an affirmative action program or to be
eligible for financial aid intended for minority students.160 Individuals have
also claimed to be Native American so that they can partake in various
benefits and opportunities reserved for established Native tribes.161 Indeed,
several companies market specifically to Native Americans.162
African Americans are also targeted by genetic ancestry companies.
Given that many African Americans cannot trace their ancestry back more
than a few generations due to the slave trade, ancestry testing is seen as a
way to surpass history’s roadblocks to give Black Americans a sense of
their ancestral linkage to the African continent.163 This can have a
tremendous impact on Blacks’ sense of identity.164

http://www.dna-worldwide.com/ancestry-testing/male-ancestry/male-dna-story (last visited Dec. 2,
2012) (claiming that “Your Y-chromosome made you the man you are today. Quite literally. It contains
the genetic switch that sent you down the path of turning you into a baby boy. But before it reached
you, your Y-chromosome had been on an incredible journey”).
159. Troy Duster, Ancestry Testing and DNA: Uses, Limits, and Caveat Emptor, in RACE AND
THE GENETIC REVOLUTION: SCIENCE, MYTH, AND CULTURE 99, 99 (Sheldon Krimsky & Kathleen
Sloan eds., 2011).
160. Amy Harmon, Seeking Ancestry in DNA Ties Uncovered by Tests, N.Y. TIMES, Apr. 12,
2006, http://www.nytimes.com/2006/04/12/us/12genes.html.
161. Kim TallBear & Deborah A. Bolnick, Native American DNA Tests: What Are the Risks to
Tribes?, NATIVE VOICE, Dec. 3–7, 2004, at D2.
162. Genelex, a company that offers genetic ancestry tests, ran this advertisement in Indian
Country Today, a newsmagazine for Native Americans:
Do you need to confirm that you are of Native American descent? Recent advances in
genetic ancestry testing have put the answer to this question at your fingertips. Whether your
goal is to assist in validating your eligibility for government entitlements such as Native
American Rights or just to satisfy your curiosity, our Ancestry DNA test is the only
scientifically rigorous method available for this purpose in existence today.
Kimberly TallBear, Native-American-DNA.com, in REVISING RACE IN A GENOMIC AGE 235, 243
(Barbra A. Koenig, Sandra Soo-Jin Lee & Sarah S. Richardson eds., 2008).
163. Bolnick et al., supra note 154, at 399.
164. In the PBS special African-American Lives, the results of ancestry tests were revealed to
several Black celebrities. When told that these tests could tell her about her heritage, Whoopi Goldberg
exclaimed, “It’s possible to find out what I am and who I am and what part? Oh my goodness!” The
results, however, are not always positive. When Oprah Winfrey’s results showed that she was not Zulu,
as she has previously believed, she was visibly disappointed. African-American Lives (PBS television
broadcast Feb. 2006).
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2. The Science Behind Genetic Ancestry Tests
Genetic ancestry testing can be understood as the commercial iteration
of scholarly research in population genetics, a field that examines how
evolutionary forces, such as migration and reproduction, shape the
distribution and frequency of various genes within particular
populations.165 Over time, these evolutionary dynamics can lead certain
markers to become strongly associated with the group itself.166 This uneven
distribution of genetic markers can provide clues to their geographic
origins, which can then point to the most closely associated population.167
Several large scale attempts, including the International HapMap Project168
and the Human Genome Diversity Project,169 have tried to map the genetic
variations most closely linked to global human populations in a manner that
ultimately gives greater biological coherence to social categories of race.
An increasing amount of research is beginning to demonstrate
connections between population differences and racial groupings. Esteban
Burchard and his colleagues note, “Studies in population genetics have
revealed great genetic variation within racial or ethnic subpopulations, but
also substantial variation among the five major racial groups.”170 This has
been demonstrated in at least three types of studies. First, population
geneticists studying global indigenous groups have created ancestral tree
diagrams “showing that the human population has major branches
corresponding to the major racial groups, with sub-branches within each
racial group associated with indigenous groups.”171 Second, researchers
have used cluster analyses that look for patterns of similarity between
population groups that “have . . . consistently resulted in the delineation of
165. See L.L. Cavalli-Sforza et al., Call for a Worldwide Survey of Human Genetic Diversity: A
Vanishing Opportunity for the Human Genome Project, 11 GENOMICS 490, 490 (1991).
166. See id.
167. Id.
168. The goal of the International HapMap Project is to “determine the common patterns of DNA
sequence variation in the human genome and to make this information freely available in the public
domain.” Int’l HapMap Consortium, The International HapMap Project, 426 NATURE 789, 789 (2003).
169. In his article outlining the origins and development of the Human Genome Diversity Project,
Cavalli-Sforza explains that the “Human Genome Diversity Project (HGDP) provides a resource that is
aimed at promoting worldwide research on human genetic diversity, with the ultimate goal of
understanding how and when patterns of diversity were formed.” L. Luca Cavalli-Sforza, The Human
Genome Diversity Project: Past, Present and Future, 6 NAT. REV. GENETICS 333, 333 (2005). CavalliSforza also notes that the HGPD “has the added benefit of providing information that is likely to prove
useful to several areas of biomedical research.” Id.
170. Esteban González Burchard et al., The Importance of Race and Ethnic Background in
Biomedical Research and Clinical Practice, 348 NEW ENG. J. MED. 1170, 1172 (2003). These five
major groups include “African American, White, Asian, native Hawaiian or other Pacific Islanders, and
American Indian or Alaska native.” Id.
171. Id.
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major genetic clusters that are associated with racial categories.”172 Third,
studies that look at the distribution of genetic variations across racial
groups have been able to identify variants that are more likely to be racespecific.173 As a whole, these three groups of studies provide the scholarly
architecture to frame some population geneticists’ assertion that social
categories of race are meaningful and observable at the molecular level.
Working from these insights, genetic ancestry companies typically use
three types of techniques to deduce individuals’ ancestry. First,
mitochondrial DNA (“mtDNA”) tests focus on the DNA passed
specifically from mother to child to test maternal links.174 Second, Ychromosome tests determine paternal ancestry by examining markers
passed from father to son.175 Last, admixture tests look at markers on nonsex chromosomes containing DNA contributions from both parents to
provide percentages of a person’s ancestry from each of the five main
continental groups.176
With mtDNA and Y-chromosome testing, companies can determine
consumers’ ancestry by comparing the individuals’ haplotypes (a set of
associated variations) to the haplotypes from samples taken from groups
indigenous to a particular geographic location.177 This method is useful for
determining whether any two people are related. In the ancestry-testing
context, however, it is used to link individuals to certain populations in
order to estimate the geographic origins of their genetic makeup.178 In
contrast, admixture mapping looks at 175 autosomal markers, which are
genetic variants thought to be closely related to particular continental
populations.179 The genetic variants chosen to identify individual ancestry,

172. Id.
173. Id. Burchard and his co-authors explain:
Allele[s] with a frequency of 20 percent or greater in one racial group, the odds are in favor
of seeing the same variant in another racial group. However, variants with a frequency
below that level are more likely to be race-specific. This race-specificity of variants is
particularly common among Africans, who display greater genetic variability than other
racial groups and have a larger number of low-frequency alleles. These results indicate that
the frequency of variant alleles underlying disease or normal phenotypes can vary
substantially among racial groups, leading to differences in the frequency of the phenotypes
themselves.
Id. (citation omitted).
174. Bolnick et al., supra note 154, at 399.
175. Id.
176. Id.
177. Id.
178. Id.
179. Id.
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known as Ancestry Informative Markers (“AIM”),180 are “those that have
the most uniqueness, or the largest differences in allele frequency among
populations.”181 For example, a company’s database of genetic samples
from populations across the globe might show that an individual shares
markers with groups from East Asia but not Europe, leading to test results
that suggest the individual has Asian ancestry. Admixture tests focus on the
relatively few genetic markers that are seemingly connected to specific
populations and are thought to provide a better overall sense of a person’s
ancestry.182
3. Risks and Benefits of Genetic Ancestry Testing
Genetic ancestry tests have the potential benefit of giving individuals
a better sense of their ancestry and racial heritage, which can be quite
fulfilling for people who feel disconnected from a larger community.
However, these technologies’ scientific limitations, along with the often
questionable marketing claims made to consumers, suggest that these tests
risk reinventing biological race in new but no less problematic terms. For
example, while genetic ancestry testing companies often resist using the
word “race” in favor of terms such as “biogeographical ancestry,” it is not
uncommon for users to consider these products to be tests of racial purity
and mixture.183
Concerns about genetic ancestry tests start with the often unnoticed
gap or logical leap between scholarly conversations about population-wide
genetic differences and the ability of tests to meaningfully reveal
individuals’ ancestral origins. The genetic boundaries that may appear to
mark population differences are not clear-cut, making the interpretation of
individual ancestry even more problematic. Anthropologist Deborah
Bolnick notes that although ancestry tests “emphasize[] the individual as
the crucial unit of analysis, individual ancestry inference is closely tied to
our understanding of human groups and the distribution of genetic
variation among them.”184 This broad concern shapes the critique of
particular techniques used to determine individual ancestry. Mitochondrial

180. Id. at 400.
181. ANTHONY FRUDAKIS, MOLECULAR PHOTOFITTING 44 (2008).
182. See Bolnick et al., supra note 154, at 399.
183. See, e.g., U.S. Patent Application No. 10/644,594, at 233 (filed Nov. 18, 2004) (using the
term “biogeographical ancestry” in a patent application for an admixture test).
184. Bolnick et al., supra note 154, at 399. The authors also point out that it is impossible to link
an individual’s DNA to that of a larger group “unless one first distinguishes groups that differ
genetically in some way. Thus, even such individually oriented genetic research has implications for
our understanding of race and the pattern of human biological diversity.” Id.
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and Y-chromosome testing examine only a very small portion of an
individual’s genome—a thin slice of the diverse genetic contributions that
we receive from our parents, grandparents, great-grandparents, and so
forth.185 For example, if an individual goes back nine generations, there are
512 great-great-great-great-great-great-great-grandparents who are each
equally influential to that person’s genetic makeup. However,
mitochondrial and Y-chromosome testing, taken together, can only provide
information for two of these individuals: the strain of genetic information
passed on from mother to child and the strain that is passed on from father
to son along the Y-chromosome. This information travels unchanged
throughout generations (mother, maternal grandmother, maternal greatgrandmother, etc. and father, paternal grandfather, and paternal greatgrandfather, etc.) and only represents information for two ancestors even
though the number of overall ancestors contributing to a person’s genome
doubles each generation.186 If each of an individual’s ancestors contributes
equally to his or her genetic make-up, why emphasize the information
gleaned from only two of them through mitochondrial and Y-chromosome
testing? In the example where we go back nine generations with 512
individuals contributing to a person’s genetic makeup, what about the other
510 people? Although genetic ancestry companies market their
mitochondrial and Y-chromosome tests as being able to tell individuals
something definitive about their race or ancestry, they are only able to
examine less than 1 percent of a person’s genetic background.187 Thus, the
strength of the assertions made by the genetic ancestry companies often
does not acknowledge these significant limitations.
Admixture testing is thought to resolve these problems because it
looks at genetic markers that are influenced by both parents, providing a
blend of information that goes beyond that available through mitochondrial
and Y-chromosome testing.188 But admixture testing discusses ancestry in
terms of percentages; for example, reporting that someone is 85 percent
European and 15 percent African.189 This presumes that racial purity
existed at some prior point in a manner that mirrors the long-discredited
polygenesis theory. This can mislead individuals into thinking that
biologically distinct racial groups are real and that social categories of race

185.
186.
187.
188.
189.

Id.
See id.
Id.
See id.
Id. at 400.
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have meaning at the molecular level.190 Moreover, the biological difference
between racial groups that admixture testing purports to objectively
discover is actually the motivating assumption behind these tests’
configuration. Anthropologist Duana Fullwiley provides a startling
example by demonstrating how one now-defunct ancestry company
collected and interpreted its data:
[T]he very continents and peoples chosen for [DNAPrint’s AIMs] product
were selected due to their perceived proximity to what we in North
America imagine race to be. Although the language of scientists who
invented this panel of AIMs is now that of “biogeographical ancestry,” the
conceptual configuration of human racial typology remains intact.191

These residual notions of racial typology are further evidenced by the
company’s patent application for its admixture test, where it
euphemistically defines “BioGeographical Ancestry” as “the heritable
component of ‘race.’”192
In addition to these concerns about technique, genetic ancestry testing
as a whole raises several broader issues. First, very few, if any, genetic
variations appear only within socially defined racial groups.193 Researchers
may be able to show the frequency of particular variations in certain
populations, but connecting an individual to a specific group—such as a
socially-defined racial group—is a process fraught with potentially perilous
assumptions.194 These variations have yet to be shown to map precisely
onto social categories of race—categories that are typically defined by

190. See id. Bolnick and her co-authors note that admixture test creates “the appearance of
genetically distinct populations,” by focusing on “ancestry informative markers” (“AIMs”) that are
believed to be indicative of specific “parental” populations. Id. However, the development of these
“parental” populations seems to have been artificially selected, and there is little evidence that such
“parental” populations ever existed. Id.
191. Duana Fullwiley, The Biologistical Construction of Race: ‘Admixture’ Technology and the
New Genetic Medicine, 38 SOC. STUDIES OF SCI., 695, 706 (2008). See also Duana Fullwiley, Can DNA
‘Witness’ Race? Forensic Uses of an Imperfect Ancestry Testing Technology, COUNCIL FOR
RESPONSIBLE
GENETICS
(2008),
http://dash.harvard.edu/bitstream/handle/1/3008240/Fullwiley_DNAWitnessRace.pdf (providing an
illuminating discussion about how the assumptions behind the construction of AIMs as markers drives
the findings of individuals’ ancestry in a manner that reflects a distinctively American understanding of
racial typology).
192. U.S. Patent Application No. 10/644,594, at [007] (filed Nov. 18, 2004).
193. Bolnick et al., supra note 154, at 400.
194. Id. Bolnick and her co-authors note that the companies that create these tests are quick to
link the occurrence of a certain allele or haplotype with a particular population, despite the fact that
“high genetic diversity exists within populations and gene flow occurs between populations.” Id.
Additionally, these companies “sometimes fail to mention that an allele could have been inherited from
a population in which it is less common,” and consumers are not made aware of the potential
shortcomings of these tests. Id. (internal citation omitted).
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physical appearance, political forces, and other social conventions.195
Given that these tests examine less than 1 percent of a person’s genetic
background, there can be a tremendous gap between the limited
information conveyed by these tests and how consumers interpret the
findings.196
Second, the results a company gives to consumers about their racial or
ancestral backgrounds are only as useful as the database samples compiled
by the company.197 The business of genetic ancestry testing relies entirely
on comparing individual profiles against a database made up of relatively
small samples of populations from across the globe.198 These databases
serve as genetic reference points under the assumption that the profiles in
the database reflect a reasonable spectrum of human genetic diversity.199
But these commercial databases are far from reflecting the true range of
genetic diversity across global populations.200 Just because an individual
“matches” in one location does not mean that he or she does not match in
others.201 This, in part, explains why it is not uncommon for individuals
who take multiple tests to receive different results.202
The third and final issue is that the claims made by genetic ancestry
companies are often not supported by the available science. It is not
uncommon for companies to make bold statements about their ability to
accurately pinpoint a person’s ancestry. For example, an advertisement by
Genetic Testing Laboratories (“GTL”) claims that its Ancestral Origins
DNA Ancestry Testing Service can “[d]iscover your [anthropological]
links. . . . [T]his simple DNA Ancestry test . . . illustrates your unique
geogenetic heritage from both a per-population view, and an overall
regional view.”203 However, claims such as these can mislead consumers
because they neglect to reveal that “present-day patterns of residence are
rarely identical to what existed in the past, and social groups have changed
195. Id.
196. Id. at 399.
197. Id.
198. “[E]ven databases with 10,000 to 20,000 samples may fail to capture the full array of human
genetic diversity in a particular population or region.” Id.
199. Id.
200. See id. Bolnick and her co-authors point out that, while these tests can identify “some of the
groups and locations around the world” a test-taker shares genetic similarities with, they are “unlikely
to identify all of them.” Id.
201. Id. at 400.
202. See Ron Nixon, DNA Tests Find Branches But Few Roots, N.Y. TIMES, Nov. 25, 2007, at 31.
203. Ancestral Origins DNA Ancestry Testing, GENETIC TESTING LABORATORIES,
https://www.gtldna.net/ancestral-origins-dna-ancestry.html (last visited Oct. 24, 2011).
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over time, [both] in name and composition. Databases of present-day
samples may therefore provide false leads.”204 Bolnick and her co-authors
note:
Worldwide patterns of human genetic diversity are weakly correlated with
racial and ethnic categories because both are partially correlated with
geography. Current understandings of race
and ethnicity reflect
more than genetic relatedness, though, having been defined in particular
sociohistorical contexts (i.e., European and American colonialism). In
addition, social
relationships and life experiences have been as
important as biological ancestry in shaping individual identity and group
membership.205

Thus, it is not only scientifically imprecise to use contemporary racial
categories and population distribution as reference points to understand
past identities and locations, but it also contradicts current scholarly
understandings concerning migration patterns and other evolutionary and
sociological dynamics.
C. DNA FORENSICS
1. Claims Made
Criminal investigators have used scientific evidence to identify and
convict criminals for centuries.206 However, when DNA technologies were
introduced in the 1980s for forensic purposes, scholars and the courts met
them with substantial skepticism.207 Traditional forensic approaches such
as latent fingerprinting were seen as more trustworthy and certain than
DNA technologies.208 Fast-forward three decades and the converse is true:
DNA is now the gold standard of evidence.209 This shift toward
overvaluing DNA evidence has been so profound that some worry about a
“CSI effect,” where prosecutors find it increasingly difficult to secure a

204. Bolnick et al., supra note 154, at 400 (internal citation omitted).
205. Id. (internal citation omitted).
206. Am. Coll. of Forensic Examiners, 1248 Early Forensic Study, HISTORY OF FORENSICS,
http://historyofforensics.com (last visited Dec. 2, 2012).
207. Michael Lynch, God’s Signature: DNA Profiling, the New Gold Standard in Forensic
Science, 27 ENDEAVOR 93, 93 (2003).
208. See id.
209. Michael Lynch, professor of Science and Technology Studies at Cornell University, suggests
that “[t]he acceptance of DNA profiling as a certain, error-free method of personal identification has
profoundly influenced the degree of trust invested in it, compared with other forms of criminological
evidence.” Id. Additionally, forms of evidence that had long been used to show guilt, such as
“handwriting analysis, lie detector tests, fiber analysis, ballistics, blood-spatter analysis, [and] bite-mark
analysis,” have now been “called into question in comparison with the new ‘gold standard’ of DNA
profiling.” Id. at 93–94.
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conviction without offering DNA evidence to a jury.210 The definitive
claim made across all forensic techniques involving DNA is that it is a
virtually infallible arbiter of identifying subjects to determine their guilt or
innocence.
2. The Science Behind DNA Forensics
Humans are over 99 percent similar to one another in terms of their
genetic makeup.211 However, the less-than 1 percent difference remaining
represents millions of individual points of genetic variation that can be used
to uniquely identify individuals.212 Buried within our genomes are
chromosomal regions called loci. Loci are sites for short tandem repeats
(“STRs”)—“stretches of DNA where the DNA replicating mechanism
appears to ‘stutter,’ resulting in different numbers of copies of repeated
sequences.”213 A four-base sequence such as CGAT might repeat several
times at a locus; each sequence and its repetition is considered a variant.214
These variants mark nearby genes because their location on the
chromosome is known; a person’s unique genetic profile can be deduced by
the number of variants across a particular set of chromosomal loci.215
Accuracy in DNA testing is improved by checking a greater number of
loci.216 Thirteen loci is the U.S. federal government’s standard for
identification; the chance that two unrelated individuals coincidentally
match at all thirteen locations is astronomically low—one in several
billion.217 Since biological samples can be amplified, only trace amounts of
blood or saliva left at a crime scene are needed to make comparisons to
known profiles.218 Polymerase chain reaction (“PCR”) is a technique that
can be used to mimic cells’ natural replication process in order to generate

210. Michael Mann, Student Article, The “CSI Effect”: Better Jurors Through Television and
Science?, 24 BUFF. PUB. INT. L.J. 211, 214–15 (2006). The “CSI effect,” named after the syndicated
television show, has led many people to think that “scientific evidence is available and irrefutable in
every criminal proceeding.” Id. This may lead some jurors to have “heightened expectation of what they
will see when they enter a courtroom,” and often leaves them looking for this type of definitive
scientific evidence in real life cases. Id.
GENES
AND
HEALTH
(2007),
available
at
211. ROCHE,
http://www.roche.com/genes_and_health.pdf.
212. Id.
213. Henry T. Greely et al., Family Ties: The Use of DNA Offender Databases to Catch
Offenders’ Kin, 34 J.L. MED. & ETHICS 248, 249 (2006).
214. Id. at 249–50.
215. Id. at 250.
216. See id.
217. Id.
218. See DAVID H. KAYE, THE DOUBLE HELIX AND THE LAW OF EVIDENCE 180 (2010).
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enough cellular material from trace amounts to make adequate
comparisons.219
Although DNA typing is typically very reliable, several problems can
arise related to the handling and interpretation of the evidence, which can
shape overall determinations of an individual’s guilt or innocence.220 This
includes problems with contamination (mixing of samples), clerical errors,
misinterpreting old or small samples, or coincidental matches.221 It is useful
to take a closer look at DNA forensics’ various applications in order to
appreciate the different techniques used to identify criminals and how this
might aggravate concerns pertaining to the reemergence of biological race.
a. DNA Databases
Since the 1990s, DNA databases have been used by local, state, and
federal law enforcement to store convicted criminals’ genetic profiles.222
This approach has been the most widespread in the United Kingdom where
genetic profiles of nearly 8 percent of the population (4.9 million people)
are on file.223 This figure represents the United Kingdom’s aggressive
policy of retaining profiles from anyone detained by the police.224 In the
early days of DNA forensics, the United States only retained profiles from
individuals convicted of serious felonies such as rape.225 In 1998, the FBI
launched CODIS, which is a federal repository for offenders’ genetic
profiles that shares information with state and local databases.226 Every
state now has statutory provisions permitting the collection of DNA from
suspects or convicts.227 The bar for inclusion varies; at least thirty-four
states authorize retaining DNA from individuals convicted of any felony,

219.
220.
221.
222.

Id. at 178–91.
See infra Part III.C.2.a.
See infra Part IV.B.
Helen Wallace, Prejudice, Stigma, and DNA Databases, in RACE AND THE GENETIC
REVOLUTION: SCIENCE, MYTH, AND CULTURE 68, 68 (Sheldon Rimsky & Kathleen Sloan eds., 2011).
223. Id. at 70.
224. Id. at 70–72.
225. “State DNA databases, which began almost exclusively as collections of adult sexual
offenders’ DNA profiles, have now expanded to include many or all convicted felons, juvenile
offenders, those convicted of certain misdemeanors, and even arrestees.” Mark A. Rothstein & Meghan
K. Talbott, The Expanding Use of DNA in Law Enforcement: What Role for Privacy? 34 J.L. MED. &
ETHICS 153, 153 (2006).
226. What is CODIS?, DNA INITIATIVE,
http://www.dna.gov/solving-crimes/cold-cases/howdatabasesaid/codis (last visited Dec. 2, 2012). See
also Michael Seringhaus, Op-Ed., To Stop Crime, Share Your Genes, N.Y. TIMES, Mar. 14, 2010, at
A23.
227. Seringhaus, supra note 226.
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while at least thirty-eight states permit taking DNA samples from
individuals convicted of certain misdemeanors.228
Several new state and federal laws are now authorizing the retention
of DNA from individuals merely arrested for certain crimes; DNA is kept
on file regardless of whether the person is ever charged or convicted. For
example, a 2006 amendment to the Violence Against Women Act allows
the Department of Justice to retain DNA from people arrested or held by
federal agents.229 Following this lead, thirteen states—including California,
Kansas, and North Dakota—now collect DNA from arrestees.230 This has
the intended effect of radically expanding the number of genetic profiles
stored by state, local, and federal governments.231 From the perspective of
law enforcement, including arrestees in DNA databases increases the
chances of finding a match while posing no threat to innocent individuals
given the precision of DNA forensics. This claim will be examined later in
this section.
b. Cold Hits, Partial Matches, and Familial Searches
One presumed benefit of expanding the number of profiles in DNA
databases through arrestee inclusion policies is the increased success of
cold hit and partial match searches. Cold hits occur when:
[T]he major or only evidence is biological material linking the defendant
to the offense. In these cases, the government has no investigatory leads,
but develops a genetic profile based upon some material left at a crime
scene. The government then runs that forensic profile in a database and
uncovers a “match”—a stored sample associated with a known person or
offender.232

With more profiles included in forensic databases, law enforcement hopes
to increase the chances that crime scene samples with currently unknown
identities will point toward a potential suspect.
It is also useful to distinguish between full and partial matches. Full
matches are the most robust; they occur when two profiles match across the
228. Seth Axelrad, Survey of State DNA Database Statutes, AM. SOC. L. MED. & ETHICS (2005),
available at http://www.aslme.org/dna_04/grid/guide.pdf (for data, see Grid: Survey of DNA Database
Statutes, AM. SOC. L. MED. & ETHICS, http://www.aslme.org/dna_04/grid/statute_grid.html (last visited
Dec. 2, 2012)).
229. Karen J. Maschke, DNA and Law Enforcement, in FROM BIRTH TO DEATH AND BENCH TO
CLINIC: THE HASTINGS CENTER BIOETHICS BRIEFING BOOK FOR JOURNALISTS, POLICYMAKERS, AND
CAMPAIGNS 45, 46 (Mary Crowley ed., 2008).
230. Id.
231. Id. at 45.
232. Erin Murphy, The New Forensics: Criminal Justice, False Certainty, and the Second
Generation of Scientific Evidence, 95 CALIF. L. REV. 721, 740 (2007).
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thirteen CODIS markers.233 Partial matches occur when two profiles match
at fewer than thirteen markers.234 Experts have testified that as few as a
nine-locus match can be used to definitively identify someone.235 Familial
searches leverage the fact that close relatives (such as siblings or a child
and a parent) share half of the same short tandem repeat lengths and genetic
variants, while uncles, aunts, and other more distant relatives share about
one quarter.236 For example, partial matches at six or seven CODIS
markers might not point directly to a suspect. But it might point to their
brother or mother, which can lead investigators to the person who
committed the crime.237 This technique was successfully used to solve the
Grim Sleeper case, in which serial killer Lonnie Franklin—alleged to have
murdered ten women over twenty-two years in Southern California238—
was captured by partially matching DNA from the crime scenes to a
California prisoner, which suggested a close relative was the culprit.239
Franklin is the prisoner’s father.240
c. Molecular Photofitting
New genetic technologies are using information in biological samples
left at crime scenes to go beyond finding suspects through cold hits or
partial matches. Technologies similar to admixture mapping are being used
to develop descriptions of suspects’ phenotypes or physical appearances. 241
One technology, called molecular photofitting, is an approach that attempts
to “produce forensically (or biomedically) useful predictions of physical
features or phenotypes from an analysis of DNA variation. . . . [to provide]

233. WILLIAM C. THOMPSON, THE POTENTIAL FOR ERROR IN FORENSIC DNA TESTING (AND
HOW THAT COMPLICATES THE USE OF DNA DATABASES FOR CRIMINAL IDENTIFICATION), COUNCIL
FOR
RESPONSIBLE
GENETICS
5
(2008),
available
at
http://www.councilforresponsiblegenetics.org/pageDocuments/H4T5EOYUZI.pdf.
234. Id.
235. Id. at 21.
236. Greely et al., supra note 213, at 251–52.
237. See id. at 252.
238. Edecio Martinez, “Grim Sleeper” Arrest: Who is Lonnie Franklin, Jr.?, CBS NEWS (July 8,
2010, 11:47 AM), http://www.cbsnews.com/8301-504083_162-20009945-504083.html.
239. David Lazer & Frederick R. Bieber, ‘Familial Searching,’ Its Promise and Perils, L.A.
TIMES, July 10, 2010, http://articles.latimes.com/2010/jul/10/opinion/la-oe-lazer-grim-sleeper-dna20100710.
240. Id.
241. These technologies “have been based primarily on genetic information about a sample
source’s recent ancestry, and to a lesser extent, on genetic information about her morphology. Forensic
analysts use ancestry and morphology information to infer a suspect’s race and general appearance.”
Pilar N. Ossorio, About Face: Forensic Genetic Testing for Race and Visible Traits, 34 J.L. MED. &
ETHICS 277, 281 (2006).
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a summary list of physical traits like height, weight, hair color, eye color,
and race, and a fuzzy or low-resolution photograph.”242
This technology was used to capture another serial killer, Derrick
Todd Lee.243 Eyewitness accounts, along with previous studies showing
that most serial killers are White, suggested that the person responsible for
several murders in Baton Rouge, Louisiana, was a White male.244
However, researchers at the now-defunct245 DNAPrint Genomics used this
technology to assess the ancestry informative markers of the biological
sample left at a crime scene.246 Their findings suggested that the suspect
was not White, but a light-skinned Black man—one with 85 percent
African and 15 percent Native American ancestry.247 This reoriented law
enforcement’s search, leading to Lee’s arrest and conviction.248

Figure 2: On the left is a police sketch of Baton Rouge serial killer, based
on eyewitness accounts. On the right is convicted serial killer Derrick Todd
Lee.249

242. FRUDAKIS, supra note 181, at 16.
243. Nancy Touchette, Genome Test Nets Suspected Serial Killer, GENOME NEWS NETWORK
(June 13, 2003), http://www.genomenewsnetwork.org/articles/06_03/serial.shtml.
244. Id.
(Mar.
3,
2009),
245. DNAPrint
Genomics
Goes
Bust,
GENOMEWEB
http://www.genomeweb.com/node/912684?emc=el&m=325264&l=1&v=e993a10706.
246. Touchette, supra note 243.
247. Id.
248. Id.
249. Id.
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3. The Risks and Benefits of DNA Forensics: The Racial Context of a
Tarnished Gold Standard
a. Whose DNA is in the Database? The Relevance of Race
Genetic technologies have played a key role in both identifying
suspects and exonerating falsely accused individuals.250 However, Blacks’
and Latinos’ routine and disproportionate contact with law enforcement
provides an important context from which to understand DNA forensics’
broader implications for racial minorities and biological understandings of
racial difference. In a 2008 study by the Pew Center for the States,
researchers showed that “for the first time, more than one in every 100
adults is now confined in an American jail or prison.”251 The 2.3 million
incarcerated American adults outnumber countries with what many
consider to be more draconian legal systems, such as China (1.5 million
incarcerated) and Russia (890,000).252 But there is concern not only with
the number of people in prison, but also the disproportionate incarceration
of racial minorities. The Pew Study shows that one in 245 Whites are likely
to be imprisoned at some point in their life compared with one in 41 Blacks
and one in 96 Hispanics.253 The numbers are even more distressing for
Black men between twenty and twenty-four, who have a one in 9 chance of
being incarcerated, and Black men between ages thirty-five and thirty-nine,
who have a one in 10 chance of being incarcerated.254 Women of color are
also incarcerated disproportionately. For example, one in 355 White
women between ages thirty-five and thirty-nine will face incarceration, as
compared to one in 100 for similarly-aged Black women.255
These numbers draw attention to law enforcement’s longstanding
practice of targeting communities of color, particularly as a function of the
war on drugs.256 These policing practices not only lead to racially

250. See INNOCENCE PROJECT, 250 EXONERATED: TOO MANY WRONGFULLY CONVICTED (2010),
available at http://www.innocenceproject.org/docs/InnocenceProject_250.pdf.
251. PEW CTR. ON THE STATES, ONE IN 100: BEHIND BARS IN AMERICA 2008, at 3 (2008),
available at http://www.pewcenteronthestates.org/uploadedFiles/One%20in%20100.pdf.
252. Id. at 5.
253. Id. at 34.
254. Id.
255. Id.
256. See JUST. POL’Y INST., THE VORTEX: THE CONCENTRATED RACIAL IMPACT OF DRUG
IMPRISONMENT AND THE CHARACTERISTICS OF PUNITIVE COUNTIES (2007), available at
http://www.justicepolicy.org/images/upload/07-12_REP_Vortex_AC-DP.pdf. The Justice Policy
Institute notes that state and federal incarcerations stemming from drug offenses rose 21 percent
between 1995 and 2003 and that there was a 47 percent increase for those in jail on drug charges during
this period. Id. at 2. It also notes that “African Americans are disproportionately incarcerated for drug
offenses in the U.S., though they use and sell drugs at similar rates to whites.” Id. In 2003, African
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disproportionate numbers in convictions, but also in arrests and
detainments. They also suggest a similar minority overrepresentation in
state and federal DNA databases. Although Blacks only make up 13
percent of the population, it has been estimated that they constitute 40
percent of the profiles in DNA databases maintained by the federal
government.257 Racial minorities’ disproportionate representation in DNA
databases suggests that this technology will increasingly place these
communities under a new and pervasive form of genetic surveillance.
These technologies’ shortcoming and overstatements regarding their
precision258 will undoubtedly have a disproportionate effect on minority
communities.259
b. Technical Shortcomings Associated With DNA Forensics
It is in this context that we can begin to assess DNA forensics’
shortcomings to understand how these applications may lead to new forms
of racial injustice. Each of these technologies has played a significant role
in identifying and ultimately convicting criminals. Yet, they also have
significant technical deficiencies that belie the claims of infallibility
surrounding DNA databases.260 First, the astronomical statistics used to
suggest the unlikelihood of coincidental matches occurring in DNA
databases may not be as strong as they initially appear.261 The premise
behind amassing large DNA databases is that individuals’ profiles across at
least nine loci are dissimilar enough to only pose an infinitesimally low risk
for coincidental matches.262 However, recent data from three state
databases show otherwise. Arizona’s state database of 65,493 offenders had
122 pairs of profiles matching at nine loci, twenty pairs at ten loci, and two
pairs of siblings each matching at eleven and twelve loci, respectively.263
Illinois’s state database of 220,000 profiles had 903 pairs matching at nine
Americans made up 13 percent of the total population, but accounted for more than half of the
sentenced drug offenders in state prisons. Id.
257. Greely et al., supra note 213, at 258.
258. See infra Part IV.B.
259. See D.H. Kaye & Michael E. Smith, DNA Identification Databases: Legality, Legitimacy,
and the Case for Population-wide Coverage, 2003 WIS. L. REV. 413, 452–53 (2003). Kaye and Smith
note that “[a]rrest, prosecution, and conviction are so pervasive in black communities that, on any given
day, a black American is five times more likely to be in jail than is a white. Id. (internal citations
omitted). The authors add that, “[w]ithout seismic changes in Americans’ behavior or in the criminal
justice system, nearly 30% of black males, but less than 5% of white males will be imprisoned on a
felony conviction at some point in their lives.” Id.
260. Jon Jefferson, Cold Hits Meet Cold Facts: Are DNA Matches Infallible?, TRANSCRIPT,
Spring 2008, at 29, 30–31.
261. Id.
262. Id. at 32.
263. Id. at 32–33.
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or more loci..264 Maryland’s state database of 30,000 profiles had thirty-two
pairs matching at nine loci and three matching at all thirteen.265 How do we
explain this unexpectedly high number of ostensibly unique profiles in the
same database matching each other? It is not clear, which is why a growing
number of scientists have requested greater access to government operated
forensic databases to better understand this problem.266 Thus far, the
government has declined.267
The problem of coincidental matches is pressing because the potential
overestimation of their rarity may lead to false convictions. There are
significant questions about the appropriate way to express this probability.
For example, police identified John Puckett in 2004 through a cold hit
DNA database search in California that matched his profile to crime scene
evidence from a 1972 murder at 5.5 loci.268 The prosecutor told jurors that
there was only a one in 1.1 million chance that the match was
coincidental.269 No other evidence connected Puckett to the crime and he
was convicted of murder based largely on this cold hit evidence.270 This
points to a debate about whether general population figures should be used
as a reference point in calculating these statistics (as they were in the
Puckett case) or the number of profiles in the relevant database. The
problem in using general population figures as a reference point is
explained by William C. Thompson, Professor of Criminology, Law, and
Society at the University of California, Irvine:
[S]uppose that a partial DNA profile from a crime scene occurs with a
frequency of 1 in 10 million in the general population. If this profile is
compared to a single innocent suspect, the probability of a coincidental
match is only 1 in 10 million. . . . By contrast, when searching through a
database as large as the FBI’s National DNA Index System (NDIS), which
reportedly contains nearly 6 million profiles, there are literally millions of
opportunities to find a match by coincidence. Even if everyone in the
database is innocent, there is a substantial probability that one (or more)

264. Linda Geddes, For Justice, Share DNA Databases, NEW SCIENTIST, Jan. 6, 2010, at 8,
available at http://www.newscientist.com/article/mg20527424.700-unreliable-evidence-time- to-openup-dna-databases.html (under the title “Unreliable Evidence? Time to Open up DNA Databases”).
265. Id.
266. See D.E. Krane et al., Letter to the Editor, Time for DNA Disclosure, 326 SCI. 1631 (2009).
267. See id.
268. Jason Felch & Maura Dolan, When a Match Is Far from a Lock, L.A. TIMES, May 4, 2008,
http://articles.latimes.com/print/2008/may/04/local/me-dna4.
269. Id.
270. Id.
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will have the 1-in-10 million profile. Hence, a match obtained in a
database search might very well be coincidental.271

If the size of the database is taken into account in Puckett’s case—a
practice recommended by expert committees convened by the FBI272 and
National Research Council273 but rarely followed—the probability that the
database has at least one profile that might coincidentally match the crime
scene evidence if the assailant’s profile is not present becomes one in
three.274
Familial searches also raise significant concerns. Since Black and
Latino profiles are disproportionately represented in DNA databases, the
expanded net of suspects created by familial searches is more likely to
affect extended families in minority communities who may have nothing to
do with the alleged crimes.275 Familial searching places “a new category of
people . . . under lifetime genetic surveillance. [DNA databases’]
composition would reflect existing demographic disparities in the criminal
justice system, in which arrests and convictions differ widely based on
race, ethnicity, geographic location, and social class. Familial searching
potentially amplifies these existing disparities.”276 Racially skewed
policing practices in the United Kingdom substantiate this concern, where
“nearly four in 10 black men . . . are on the police’s national [DNA]
database—compared with fewer than one in 10 white men.”277 As noted
earlier in this section, a similar racial architecture is evolving in local, state,
and federal databases in the United States, giving rise to substantial civil
liberty concerns about the way in which this technology is used. Familial
searches include greater proportions of minority communities as possible
suspects because these searches implicate those who are merely related to

271. THOMPSON, supra note 233, at 10. The one in 1.1 million figure in the Puckett case used the
population figure as a referent.
272. FBI DNA Advisory Bd., Statistical and Population Genetics Issues Affecting the Evaluation
of the Frequency of Occurrence of DNA Profiles Calculated from Pertinent Population Database(s),
SCI.
COMM.,
July
2000,
available
at
FORENSIC
http://www2.fbi.gov/hq/lab/fsc/backissu/july2000/dnastat.htm.
273. NAT’L RESEARCH COUNCIL, THE EVALUATION OF FORENSIC DNA EVIDENCE: AN UPDATE
(1996), available at http://www.nap.edu/openbook.php?record_id=5141.
274. Felch & Dolan, supra note 268. See also David Kaye, Taking Liberties With the Numbers,
&
L.
BLOG,
April
18,
2009,
available
at
SCI.
http://lawprofessors.typepad.com/science_law/2009/week16/index.html.
275. Greely et al., supra note 213, at 258.
276. Frederick R. Bieber, Charles H. Brenner & David Lazer, Finding Criminals Through DNA
of Their Relatives, 312 SCIENCE 1315, 1316 (2006).
277. James Randerson, DNA of 37% of Black Men Held by Police, THE GUARDIAN (Jan. 4,
2006), http://www.guardian.co.uk/world/2006/jan/05/race.ukcrime.
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someone in the database. Simon Cole, Associate Professor of Criminology,
Law, and Society at the University of California, Irvine, notes:
Familial searching exacerbates the discriminatory effects of database
composition. . . . [I]nclusion of an individual in a database effectively
adds that individual’s close relatives to the database as well. In the context
of an arrestee database, in a society in which young African-American
males have a one in three chance of experiencing some form of state
custody, this could quickly result in effectively incorporating entire
neighborhoods and ethnic communities into the database.278

The concerns with molecular photofitting are similar to those with
genetic ancestry testing to the extent that they rely upon a similar
underlying technology of admixture testing; estimations are crude and
based on databases with significant limitations, are often proprietary, and
are not routinely subjected to peer review.279 These concerns are amplified
significantly when moved from the context of recreational genetics to
criminal investigations. Some geneticists have questioned the underlying
theory of admixture testing, which is based on assumptions about human
population structure that are incongruent with mainstream evolutionary
understandings of human ancestry.280 This raises a profound question at the
intersection of law and science: Is it appropriate to use a technology to
identify and convict individuals that is based on a theory that is not fully in
line with basic Darwinian premises at the heart of modern science?
By treating racial identity as something that can be measured and
verified through scientific methods, DNA forensic applications such as
molecular photofitting play a direct role in reconstituting the biological
significance of racial difference. But other dynamics such as DNA
databases’ expanding uses and racially disproportionate composition may
play a more insidious role in the re-emergence of biological race by
emphasizing links between race and criminality. This can shape both public
perceptions and future research agendas in terms of how we understand the
relationship between race, crime, and genetics.

278. Simon A. Cole, How Much Justice Can Technology Afford? The Impact of DNA Technology
on Equal Criminal Justice, 34 SCI. & PUB. POL’Y 95, 102 (2007) (internal citation omitted).
279. Bolnick et al., supra note 154, at 400 (discussing shortcomings of admixture testing).
280. Kenneth M. Weiss & Jeffrey C. Long, Non-Darwinian Estimation: My Ancestors, My
Genes’ Ancestors, 19 GENOME RES. 703, 705, 708 (2009) (noting that these tests place “heavy emphasis
on the idea that the world once harbored distinct and independently evolved populations that have now
undergone admixture of an unstated type,” despite the fact that this concept of genetic ancestry is “more
in line with race concepts held by European explorers and traders than with the recent genetic evidence
supporting the serial sampling model of human evolutionary history”).
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Sociologist Troy Duster argues that the confluence of these forensic
applications raises the specter of a twenty-first century phrenology, noting
that, while “[o]ne could do a SNP profile of rapists and sex offenders, and
find some markers that they putatively share,” these markers will be
“precisely that, ‘markers,’ and not explanatory of ‘the causes’ of violent
crime.”281 Such a proposal would not be unprecedented. In the 1990s,
several federal administrators proposed a failed plan called the Violence
Initiative, which was based on two premises: “The first was that much of
violent behavior in the inner city may have biological or genetic origins.
The second premise was that ‘factors of individual vulnerability and
predisposition to violent behavior exist—factors that may be detected at an
early age.’”282 Frederick Goodwin, then head of the Alcohol, Drug Abuse,
and Mental Health Administration and Violence Initiative noted in a 1992
address that the Initiative’s purpose was to “design and evaluate
psychosocial, psychological, and medical interventions for at-risk children
before they become labeled as delinquent or criminal. This is the basic
point of it all . . . identifying at-risk kids at a very early age before they
have become criminalized.”283 Given that today’s DNA databases function
as an existing repository of what many consider to be criminal genes, future
research linking genes and criminal outcomes is not far-fetched. Nor is it
far-fetched to think that these databases’ racially disproportionate
composition will place race at the center of this discussion.
IV. TOWARD RACE IMPACT ASSESSMENTS
A. THE PERSISTENCE OF TYPOLOGICAL THINKING ABOUT RACE IN
SCIENCE
Race-based medicines, genetic ancestry tests, and DNA forensics can
each potentially benefit racial minorities and society in general by
providing life-saving medicines targeted for vulnerable and underserved
populations, increasing individuals’ knowledge about their ancestry, and

281. Troy Duster, Selective Arrests, An Ever-Expanding DNA Forensic Database, and the
Specter of an Early-Twenty-First Century Equivalent of Phrenology, in DNA AND THE CRIMINAL
JUSTICE SYSTEM: THE TECHNOLOGY OF JUSTICE 315, 315 (David Lazer ed., 2004).
282. Vernellia R. Randall, Slavery, Segregation and Racism: Trusting the Health Care System
Ain’t Always Easy! An African American Perspective on Bioethics, 15 ST. LOUIS U. PUB. L. REV. 191,
227 (1996).
283. Garland E. Allen, Modern Biological Determinism: The Violence Initiative, the Human
Genome Project, and the New Eugenics, in THE PRACTICES OF HUMAN GENETICS 1, 1 (Michael Fortun
& Everett Mendelsohn eds., 1999) (quoting Frederick K. Goodwin, Conduct Disorder as A Precursor to
Adult Violence and Substance Abuse: Can the Progression be Halted, Address to the American
Psychiatric Association (May 5, 1992)).
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offering tools to law enforcement to help solve crimes. However, these
technologies are also united by a tendency to promote typological
perspectives on race that are reminiscent of the nineteenth and early
twentieth centuries when “pure” or “real” races were thought to
independently exist and each race was thought to share a set of unique
biological traits that could be identified and measured.284 This contrasts
with mainstream scientific perspectives that view the distribution of human
traits on a continuum that does not have the discrete breaks that typologists
find indicative of biological race.285
Despite this tension, biological race continues to be salient in lay and
scientific discourses. Increasing public exposure to race and genetics
research is shaping lay opinions about the relevance of genes to racial
disparities in social and health outcomes.286 At the same time, scientists
continue to espouse typological approaches that give coherence to
biological understandings of racial difference. Sociologist Ann Morning,
who has conducted research on scientists’ perspectives on race, observes
that:
[S]ocial and biological scientists hold a wide range of beliefs about the
nature of racial difference; contrary to some scholars’ expectations, they
are far from any consensus, either within or between disciplines. . . . [T]he
essentialist proposition that races are biologically grounded entities
remains a compelling view for many contemporary scientists.287

This all leads to an important question: Given law’s past complicity in
furthering racial subordination through promoting biological race, what
normative role should government take in regulating new biotechnologies
that advance biological understandings of racial difference? This is a
difficult question because the social and scientific contexts have changed
between past articulations of biological race and today’s innovations, but
the potential risks to racial minorities remain quite similar. While overly
strict regulations might unduly prevent access to life-saving or lifeenhancing technologies, overly permissive approaches may lead to new
284. Ernst Mayr, Typological Versus Population Thinking, in CONCEPTUAL ISSUES IN
EVOLUTIONARY BIOLOGY 325, 327 (Elliott Sober ed., 3d ed. 2006) ( “The typologist stresses that every
representative of a race has the typical characteristics of that race and differs from all representatives of
all other races by the characteristics ‘typical’ for the given race. All racist theories are built on this
foundation. Essentially, it asserts that every representative of a race conforms to the type and is
separated from the representatives of any other race by a distinct gap.”).
285. See id. at 326–28.
286. See generally, Celeste M. Condit et al., The Role of “Genetics” in Popular Understandings
of Race in the United States, 13 PUB. UNDERSTANDING OF SCI. 249 (2004).
287. ANN MORNING, THE NATURE OF RACE: HOW SCIENTISTS THINK AND TEACH ABOUT
HUMAN DIFFERENCE 221 (2011).

OBASOGIE FINAL V3

2012]

2/26/2013 1:33 PM

The Return of Biological Race?

51

forms of racial subordination and promote an impoverished understanding
of race among the public.
B. REGULATORY GULF: EXPANDING USES, DIMINISHING OVERSIGHT
Biotechnologies that implicate race are expanding in their use and
development. For example, biologists Sarah Tate and David Goldstein
observed in a 2004 Nature Genetics article that, while controversial, “[a]t
least 29 medicines (or combination of medicines) have been claimed, in
peer-reviewed scientific or medical journals, to have differences in either
safety or, more commonly, efficacy among racial or ethnic groups.”288 This
suggests that more race-based medicines such as BiDil are in development
and may very well be on their way.289 Additionally, genetic ancestry tests
are also becoming increasingly popular. Bolnick and several colleagues
note that “[a]t least two dozen companies now market ‘genetic ancestry
tests,’ . . . [and that m]ore than 460,000 people have purchased these tests
over the past 6 years, and public interest is still skyrocketing.”290 Most
recently, scholar Henry Louis Gates Jr. and others joined 23andMe as
advisors to the direct-to-consumer genetics company’s “Roots into the
Future” program, which hopes to attract 10,000 African Americans to its
ancestry testing services.291
New applications of DNA forensics are probably expanding the
fastest. For example, Murphy notes that while
it took Virginia nearly eight years, from 1993 to 2001, to reach its first
1,000 ‘cold hits,’ the state reached its second 1,000 in a matter of eighteen
months. Since 2001, the laboratory has averaged at least one ‘cold hit’ a
day, and as of July 2002, that figure had doubled to two and one half hits
a day.292

288. Sarah K. Tate & David B. Goldstein, Will Tomorrow’s Medicines Work for Everyone?, 36
NATURE GENETICS SUPP. S34, S34 (2004). They then note that “these claims are universally
controversial and there is no consensus on how important race or ethnicity is in determining drug
response.” Id.
289. For an example of ongoing research on race-based pharmacogenomics, see Jieming Chen et
al., Interethnic Comparisons of Important Pharmacology Genes Using SNP Databases: Potential
Application to Drug Regulatory Assessments, 11 PHARMACOGENOMICS 1077 (2010).
290. Bolnick et al., supra note 154, at 399.
291. According to 23andMe’s announcement of the project, Roots into the Future will “help
determine how genetic factors contribute to the development of disease in this population,” and “aligns
with 23andMe’s broader mission of empowering individuals to understand their own genetic data.”
23andMe, Roots into the Future: A New 23andme Research Initiative for African-Americans, SPITTOON
(July 26, 2011, 5:00 AM), http://spittoon.23andme.com/2011/07/26/roots-into-the-future/. Those who
participate in the project will receive “free access to their personal genetic data used for the research, as
well as health and ancestry interpretations of the data.” Id.
292. Murphy, supra note 232, at 740.
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Applications such as molecular photofitting are being developed to achieve
higher levels of sophistication, while practices like familial testing are
becoming increasingly commonplace in criminal investigations.293 For
example, the California Attorney General’s office has issued guidelines for
familial testing for its state database,294 which will likely accelerate the use
of this technology by state and local law enforcement.295
At the same time that these technologies are expanding, regulatory
oversight of their scientific rigor and public impact remains inadequate.
The FDA does not subject new drug applications seeking race-specific
labeling to any other standard outside the agency’s traditional emphasis on
safety and efficacy.296 Direct-to-consumer genetic tests have been criticized
by some federal agencies including the FTC,297 but the specific issues
related to race and genetic ancestry have not been a significant part of the
conversation. Genetic ancestry tests fall outside of the FDA’s regulatory
authority because “[a] genetic test is only subject to FDA oversight if it is a
medical device . . . whereas a test to determine ancestry is not a device.”298
Moreover, the FBI, in coordination with state and local law enforcement
agencies, continues to expand DNA forensics into questionable areas such
as familial testing and molecular photofitting. These applications can

293. See supra Part III.C.2.b.
294. See Information Bulletin from Lance Gima, Chief, Bur. Forensic Svcs. & Edmund G.
Brown, Jr., Cal. Att’y Gen. to All Cal. Law Enforcement Agencies & Dist. Atty’s Offices, DNA Partial
Match (Crime Scene DNA Profile to Offender) Policy (2008), available at
http://ag.ca.gov/cms_attachments/press/pdfs/n1548_08-bfs-01.pdf.
295. See Maura Dolan, State to Double Crime Searches Using Family DNA, L.A. TIMES (May 9,
2011), http://www.latimes.com/news/local/la-me-familial-dna-20110509,0,3088333,full.story.
296. See Winickoff & Obasogie, supra note 29, at 278 (arguing that “the FDA should deploy a
heightened standard of efficacy when approving race-specific indications”).
297. See At Home Genetic Tests: A Healthy Dose of Skepticism May Be the Beset Prescription,
TRADE
COMMISSION
(July
2006),
FEDERAL
http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea02.shtm. In a notice to consumers, the FTC
wrote:
According to the Food and Drug Administration (FDA), which regulates the manufacturers
of genetic tests; and the Centers for Disease Control and Prevention (CDC) . . . some of
these tests lack scientific validity, and others provide medical results that are meaningful
only in the context of a full medical evaluation. The FDA and CDC say that because of the
complexities involved in both the testing and the interpretation of the results, genetic tests
should be performed in a specialized laboratory, and the results should be interpreted by a
doctor or trained counselor who understands the value of genetic testing for a particular
situation.
Id.
298. Jeffrey Shuren, Dir., Ctr. for Devices & Radiological Health, F.D.A. Statement Before the
U.S. House of Representative Subcommittee on Oversight and Investigations Committee on Energy and
Commerce: Direct-to-Consumer Genetic Testing and the Consequences to the Public (July 22, 2010),
available at http://www.fda.gov/NewsEvents/Testimony/ucm219925.htm.
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significantly impact minority communities, as well as alter public
understandings of race.299 Therefore, a more robust regulatory response is
needed to ensure that these innovations do not legitimize biological
understandings of race in a manner that supersedes their potential benefits.
C. EXISTING PROPOSALS
While the issue of race and genetics has received substantial attention
from legal scholars, there have been relatively few proposals for how law
can balance the benefits and potential harms of human biotechnologies that
implicate race. Scholars have attempted to provide broad regulatory
guidance for how racial categories should be used in human biotechnology
beyond the various federal mandates that require the inclusion of minorities
in clinical trials.300 For example, Dorothy Roberts assesses various legal
constraints on race-based research—including regulations on federallyfunded research, civil rights statutes, and state laws—to suggest a social
justice framework based upon Equal Protection norms.301 This social
justice approach “explore[s] how the law might seriously enforce the view
that race is an unscientific and pernicious classification of human beings at
the same time that systemic racism produces health inequities.”302 Law
professor Jonathan Kahn similarly draws on Equal Protection norms to
propose a series of guidelines for how and when scientists use social
categories of race in connection with biomedical research.303 He argues for
requiring “a tight fit (a) between the population, racial/ethnic, and genetic
categories being used and (b) between the genetic category identified and
the disease state/health issue or other biological activity being analyzed.”304
Law professors Erik Lillquist and Charles Sullivan offer a comprehensive
examination of existing legal regimes to discuss various constraints
associated with using race in biomedical research.305 They argue that
“[r]acial differences in treatment (including diagnostic screening) should be
permissible only in rare circumstances where there is a bona fide treatment
rationale . . . [and] race [is] the best available method at the time.”306 In
assessing the Court’s colorblind norms in its Equal Protection
jurisprudence, law professor Kimani Paul-Emilie develops the notion of
299.
300.
301.
302.
303.
304.
305.
306.

See supra Part III.C.2.b.
Kahn, Genes, Race, and Population, supra note 29, at 7 (internal citation omitted).
See generally Roberts, supra note 29.
Id. at 531.
Kahn, Genes, Race, and Population, supra note 29, at 9.
Id.
Lillquist & Sullivan, supra note 29, at 483.
Id.
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“racial pragmatism” to find a set of residual guidelines for when the
government may appropriately take race into consideration in biomedical
research.307 My own work in this area employs the notion of strict scrutiny
found in Equal Protection law to develop oversight mechanisms for drugs
seeking race-specific indications,308 and also to set a standard of review for
FDA advisory committees.309
Each of these proposals offers significant insight on how to fill the
remarkable gap in regulatory oversight regarding race and human
biotechnology. However, at least two characteristics may lead these efforts
to not be fully responsive to existing challenges. First, existing proposals
for greater oversight of new genetic technologies that implicate biological
race tend to focus on biomedicines without examining how these issues
play out in other realms—most notably, genetic ancestry tests and DNA
forensics. Taken together, race-based medicines, ancestry tests, and DNA
forensics have synergistic effects that are much greater than the individual
applications, yet the trend is to analyze each application in isolation. By
failing to develop regulatory mechanisms that approach the race and
genetics issue holistically in terms of the multiple sites where these
technologies can recreate notions of biological race, existing proposals may
not be able to have their intended impact. Second, these proposals tend to
look to existing laws—especially Equal Protection jurisprudence—for a
source of normative guidelines from which to abstract and apply to the
emerging and quickly changing area of race and human biotechnology.
This approach has limitations, as it looks backward and sideways to how
law has treated race to think prospectively and normatively about how
regulators ought to oversee these technologies. This approach lacks the
flexibility to adjust to fundamentally different contexts and claims
connected to these technologies. What is needed is not only normative
guidelines, but also a deliberative space where we can fluidly discuss
oversight mechanisms, specific challenges raised by new technologies, and
the technologies’ impact on certain communities.

307. Paul-Emile, supra note 29.
308. Winickoff & Obasogie, supra note 29, at 278.
309. For my argument that advisory committees should use a “strict scrutiny framework” to
review new drugs that propose race-specific indications, see Osagie K. Obasogie, Beyond Best
Practices: Strict Scrutiny as a Regulatory Model for Race-Specific Medicines, 36 J.L. MED. & ETHICS
491, 496 (2008).
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D. THE NEED FOR ADMINISTRATIVE AGENCY IMPACT ASSESSMENTS ON
RACE AND HUMAN BIOTECHNOLOGY
Each application discussed in this Article falls under the
administrative authority of an existing government agency that can set
standards for how the public engages these innovations: the FDA for racebased medicines, the FTC for genetic ancestry tests, and the FBI for DNA
forensics. As discussed earlier in this section, existing regulatory
approaches to these applications by these agencies are thin; race simply is
not taken seriously as a regulatory matter despite the potential risks that
these applications portend for reinventing biological race in a manner that
may disadvantage minorities.
To avoid these risks and to give minorities access to potential benefits
that may stem from these technologies, I propose race impact assessments
as a new tool for administrative agencies that are responsible for overseeing
any new biotechnology that implicitly or explicitly makes a claim about the
biological significance of social categories of race, or that may
disproportionately affect minority communities. Generally, impact
assessments are evaluative mechanisms used by government agencies to
analyze the risks and benefits of new proposals so as to promote individual
and social well-being. Most notably, environmental impact assessments
have played a significant role in making sure that government agencies
consider the potential consequences that a new project or initiative might
have on the environment before moving forward.310 The National
Environmental Policy Act (“NEPA”), signed into law in 1970,311 requires
federal agencies to determine whether certain proposed actions—road
construction, building construction, etc.—might have an adverse effect on
the human environment.312 NEPA’s most significant legal requirement is

310. Impact assessments have been used widely in environmental studies, where environmental
impact assessments have been used to analyze “the environmental implications of a decision to enact
legislation, to implement policies and plans, or to initiate development projects.” Peter Wathern, An
Introductory Guide to EIA, in ENVIRONMENTAL IMPACT ASSESSMENT: THEORY AND PRACTICE 3, 3
(Peter Wathern ed., 1998). However, this Article focuses on the use of impact assessment in analyzing
issues that directly affect human social, legal, or health outcomes.
311. National Environmental Policy Act of 1969, Pub. L. No. 91-190, 83 Stat. 852 (codified as
amended at 42 U.S.C. §§ 4321, 4331–35, 4341–47 (2012)).
312. NEPA requires agencies to “include in every recommendation or report on proposals for
legislation and other major federal actions significantly affecting the quality of the human environment”
an environmental impact statement. 42 U.S.C. § 4332(C). These statutory requirements have been
defined within the Code of Federal Regulations. 40 C.F.R. § 1502.3. For specific definitions, see §
1508.23 (defining “on proposals”), § 1508.17 (defining “for legislation”), § 1508.18 (defining “other
major federal actions”), § 1508.27 (defining “significantly”), §§ 1508.3, 1508.8 (defining “affecting”
and “effects”), and § 1508.14 (defining “the quality of the human environment”).
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the Environmental Impact Statement (“EIS”).313 Generally, agencies will
first conduct an initial environmental assessment.314 This initial assessment
determines if a proposed action might have an adverse effect on the human
environment that requires an EIS.315 The more rigorous EIS process seeks
to flesh out the potential harms of a proposed action and determine if viable
and less disruptive alternatives exist.316 According to 40 C.F.R § 1502.1,
the purpose of an EIS is to “serve as an action-forcing device to insure that
the policies and goals defined in the Act are infused into the ongoing
programs and actions of the Federal Government.”317 Brian Cole and his
co-authors note that “[t]he authors of NEPA recognized . . . that [the]
problems in one sector are shaped to a large extent by actions in other
sectors[,] . . . [whereby] the assessment and consideration of environmental
impacts has become a routine part of decision making in federal, state, and
local agencies.”318 Thus, the major achievement of environmental impact
assessments has been to change the culture of administrative agencies by
raising awareness and improving sensitivity to the way that federal actions
can damage the environment and to the crucial role that regulatory agencies
can play in mitigating these harms.
Much of this cultural change has occurred through the
interdisciplinary and cooperative nature of environmental impact
assessments as dictated by federal law.319 By simultaneously engaging in
prospective assessment of potential impacts and making these findings
publically available for comment and feedback, environmental impact
statements have been able to institutionalize environmental concerns and an
ethos of public engagement into regulatory agencies’ organizational
behavior.320 In doing this, NEPA and its environmental impact statements

313. 42 U.S.C. § 4332(C)(i).
314. 40 C.F.R. § 1508.9.
315. Id. Some proposals may not require an initial environmental assessment or an EIS if they fall
into a categorical exclusion or “a category of actions which do not individually or cumulatively have a
significant effect on the human environment.” Id. § 1508.4. Other proposals may not require an EIS if
after an environmental assessment, agencies conclude with a “finding of no significant impact.” Id.
§ 1508.13.
316. 42 U.S.C. § 4332(C)(i)–(iv).
317. 40 C.F.R. § 1502.1.
318. Brian L. Cole et al., Prospects for Health Impact Assessment in the United States: New and
Improved Environmental Impact Assessment or Something Different?, 29 J. HEALTH POL. POL’Y & L.
1153, 1157 (2004).
319. 40 C.F.R. § 1502.6 (2012) (stating that “[e]nvironmental impact statements shall be prepared
using an inter-disciplinary approach which will insure the integrated use of the natural and social
sciences and the environmental design arts”).
320. Serge Taylor notes that:
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have led to better “integration of environmental goals into agency decision
making, improved planning, and transparency and public involvement for
improved agency decision making.”321 These successes have led to impact
assessment proposals in other areas of federal oversight. For example,
health impact assessments (“HIAs”) have been proposed to identify
activities and policies “likely to have major impacts on the health of a
population in order to reduce the harmful effects on health and to increase
beneficial effects.” 322 HIAs evaluate the potential health impacts of a
proposal based on “a broad model of health, which proposes that economic,
political, social, psychological, and environmental factors determine
population health,” and take into consideration the “opinions and
expectations of those who may be affected by a proposed policy.”323
Scholars have proposed other types of impact assessments that draw on
these themes. For example, social impact assessments have been developed
as a way to “analy[ze] . . . and manag[e] the intended and unintended
consequences on the human environment of interventions . . . and social
change processes so as to create a more sustainable biophysical and human
environment.”324 Similarly, human rights impact assessments have been
suggested to “help evaluate the effects of public health policies on human
rights and dignity.”325
Impact assessments of this nature share at least three relevant
characteristics that are informative for developing race impact assessments.
First, impact assessments are evidence-based; data collection is central to
the regulatory decision-making process. No one type of data is privileged;
“[b]efore the National Environmental Policy Act, most federal agencies paid scant attention
to environmental values. Since the advent of NEPA, environmental concerns have been
officially incorporated into every agency’s charter. . . . [W]hen the inside analysts are able to
explore the possible environment-development trade-offs of a wide range of alternative
designs, environmentally better decisions are likely to result: all projects benefit from
relatively inexpensive environmental mitigation. When in addition, environmentally
concerned outsiders pay attention to the EIS process, some of the worst projects – those
projects with the greatest environmental costs and little political support within the agency
and among its other constituents – get eliminated.”
SERGE TAYLOR, MAKING BUREAUCRACIES THINK: THE ENVIRONMENTAL IMPACT STATEMENT
STRATEGY OF ADMINISTRATIVE REFORM 251 (1984)
321. Cole et al., supra note 318, at 1167–68.
322. N. & Y. PUB. HEALTH OBSERVATORY., AN OVERVIEW OF HEALTH IMPACT ASSESSMENT 1
(2001), available at http://dro.dur.ac.uk/5613/1/5613.pdf.
323. Id.
324. Frank Vanclay, Social Impact Assessment 2 (World Comm. On Dams, Working Paper,
2000), available at http://www.scribd.com/doc/81829611/Social-Impact-Assessment-Vanclay.
325. Lawrence Gostin & Jonathan M. Mann, Towards the Development of a Human Rights
Impact Assessment for the Formulation and Evaluation of Public Health Policies, 1 HEALTH & HUM.
RTS. 59, 60 (1994).
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impact assessments can be quantitative or qualitative. These assessments
place a premium on engaging with, and thinking through, various policy
proposals’ real-world implications. As a second related trait, impact
assessments are multidisciplinary. Just as no one type of data is privileged,
neither is any one disciplinary approach. To be sure, the strength of impact
assessments stem from their use of multiple methods and multiple
disciplinary perspectives so as to provide a holistic analysis of the many
ways in which health, society, human rights, or any other issue may be
affected by a particular proposal. Third, impact assessments are
characterized by involving multiple stakeholders. While many of the issues
analyzed by impact assessments are highly technical and deeply embedded
in cutting-edge science, impact assessments are used to bring a wide range
of people—experts, non-experts, community members, and others—in a
deliberative and collaborative effort to ensure that decision makers are
informed of all perspectives.326
These fundamental characteristics of impact assessments produce at
least three significant benefits. First, impact assessments help root-out
facially innocuous practices that may have harmful effects. By being
sensitive to topics such as the environment, health, or human rights and
how federal decision making can affect them, policy makers can anticipate
and mitigate unintended harms—especially those affecting vulnerable
populations. A second benefit is that impact assessments increase
cooperation and deliberation between government agencies, experts, and
the public. The enhanced contact and communication between these
various stakeholders encourages a more deliberative democracy by creating
a process involving multiple levels of engagement and accountability.327
Third, the collaborative effort facilitated by impact assessments encourages
multiple government agencies to engage with one another about their
shared responsibilities. This decreases the likelihood of important issues
falling in between regulatory gaps where agencies can end up pointing the
finger at each other.
These traits and benefits suggest that the implementation of race
impact assessments would significantly assist administrative agencies in
predicting the risks and benefits of biotechnologies that implicate race so as
326. “Involving stakeholders has been recommended as essential for building interest in a project
and promoting the potential use of the results. It is important to involve stakeholders from an early stage
in the project to promote ownership.” J. Mindell et al., Enhancing the Evidence Base for Health Impact
Assessment, 58 J. EPIDEMIOL. & CMTY. HEALTH 546, 548 (2004).
327. See, e.g., AMY GUTMAN & DENNIS THOMPSON, WHY DELIBERATIVE DEMOCRACY? (2004);
AMY GUTMAN & DENNIS THOMPSON, DEMOCRACY AND DISAGREEMENT (1996).
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to mitigate the former and promote the latter. Not only do race impact
assessments provide an opportunity for a broad appraisal of the scientific
claims made by race-based medicines, genetic ancestry tests, and DNA
forensics, but they also provide a forum where multiple stakeholders—such
as government officials, scientists, constituency based groups, and others—
can exchange ideas. These stakeholders will be able to provide guidance on
how the public can gain access to biotechnologies’ potential benefits
without unduly subjecting racial minorities to the risks associated with
government reasserting questionable linkages between race and biology.
Impact assessments are not entirely unproblematic.328 For example,
the assessment process can be quite lengthy and take several years. This is
particularly troublesome with regards to potentially lifesaving medicines or
law enforcement practices that can solve open cases and prevent future
crimes. Second, impact assessments are resource-intensive and can be
costly. Who is going to pay for these assessments and who has time outside
of their regular professional and daily obligations to participate in another
round of bureaucratic fact-finding? In addition to these hurdles, there is
also a concern that, without any substantive or normative claims supporting
them, impact assessments can become a mere procedural tool that may not
be able to create the change they seek. The impact assessment process may
be vulnerable to co-optation by contrary interests that may work against the
very concerns giving rise to the assessment process itself and further
legitimize questionable and unquestioned practices.
These are surely important concerns. But they are not insurmountable,
given the remarkable stakes at hand. The unchecked proliferation of
biological race has been at the center of some of the most brutal acts in
human history. While those who promote new biotechnologies that
implicate race often have laudable objectives, it is important to remain
aware of the possible dangers. Given the government’s historical
complicity in promoting biological race in a manner that harmed the most
vulnerable members of society,329 it has a moral and ethical responsibility
to support race impact assessments to atone for past wrongs and to promote
a future where minorities can partake in the benefits of scientific innovation
without remaining perpetually vulnerable to its risks. Moreover, while the
risk of co-optation is real, improving and diversifying deliberations while

328. For an extended discussion of the challenges associated with environmental impact
assessments, see Cole et al., supra note 318, at 1169.
329. See supra Part II.
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making the process more transparent—practices embedded in the impact
assessment process—can be effective checks.
E. MODELING RACE IMPACT ASSESSMENTS: INITIAL FRAMING AND
FUTURE DIRECTIONS
This Article’s aim and scope are purposefully modest in that I have
only sought to (1) identify biological race as a historical concern with
contemporary significance; (2) describe the ways that the State has
promoted biological race to the detriment of vulnerable populations; (3)
highlight the reemergence of biological race through the development of
new biotechnologies; (4) identify the current regulatory gaps that may
inadvertently give renewed legitimacy to biological race and its harmful
ideologies; and (5) propose administrative agency race impact assessments
as a tool to balance the potential risks and benefits of new biotechnologies
that implicate race. It would be premature to propose a full race impact
assessment model at this point; successful impact assessments need to
develop out of robust empirical examinations of each agency’s
organizational design and culture in relation to current decision making
processes on race related innovations—information that is not yet fully
available. Moreover, mature impact assessments require the collaboration
of experts across multiple fields and affected stakeholders to create model
tools that balance new technologies’ potential benefits with the potential
risks of reifying social categories of race as biologically significant lines of
human difference. However, it may be productive to sketch the next steps
that need to be taken to move this conversation forward while also broadly
mapping the ways in which race impact assessments might be integrated
into federal agencies as part of their review of new technologies that
implicate race.
As an initial matter, it is important to note that, before any agency
moves forward with an assessment of this nature, it would need some type
of statutory authority—like NEPA—from which to proceed. NEPA
provides an excellent model that Congress can mimic to charge federal
agencies to engage in holistic assessments of projects, innovations, or
proposals that fall under their administrative authority that may potentially
harm race relations by promoting biological understandings of racial
difference and disparities. Like the environment, race can be seen as a
shared and connected ecosystem that requires federal protection for the
benefit of human health and social relations. Moreover, just as NEPA
established a Council on Environmental Quality (“CEQ”) within the
Executive Branch to assist the President in overseeing NEPA’s
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implementation across federal agencies,330 so too could a similar council
within the Executive Branch play a key role regarding racial issues.331 This
council could monitor the diverse ways in which race may be implicated in
administrative agency decisionmaking—from new drug applications to
innovative forensic technologies—and encourage consistency across
federal administrative agencies.
Creating this statutory authority is an important first step to making
race impact assessments a viable tool for administrative agencies seeking
further guidance on how to assess claims pertaining to the biological
significance of race. Like NEPA, the point of this statutory language is not
to compel federal agencies to take certain pre-determined actions.332
Rather, it is to institutionalize a process within administrative agencies that
gives policymakers and bureaucrats the opportunity to pause, think about
the racial implications of their actions, engage outside experts and
community stakeholders as part of the data collection process, and to use
the results of these consultations and assessment tools to inform whatever
final decision they might come to. Thus, the goal of race impact
assessments is not to say that race can never be used in new innovations
regarding human biotechnology. Instead, it is simply to say that we should
think clearly about its use so as to avoid applications that uncritically reify
race as a biological trait when all available evidence suggests approaching
this trend with skepticism.
To the extent that each administrative agency has a distinct history,
organizational structure, and awareness of how race impacts their
regulatory authority, much more work is needed to determine the most
productive way to develop and incorporate race impact assessments into
each agency’s decision making process. Since the directives and decisionmaking structures are fundamentally different in the FDA, FTC, and FBI,
there is no one-size-fits-all race impact assessment tool that can be
imported into each agency to address these matters. Before impact

330. 42 U.S.C. §§ 4342–4347 (2012).
331. In the environmental context, the CEQ’s regulations “set the standard for NEPA
ENVIRONMENTAL
POLICY
ACT,
compliance.”
B.
Nepa
Regulations,
NATIONAL
http://ceq.hss.doe.gov/welcome.html (last visited Dec. 2, 2012). In addition, the CEQ requires that
agencies create their own procedures for implementing NEPA, and makes sure that these procedures
“meet the CEQ standard while reflecting each agency's unique mandate and mission.” Id.
332. “[T]here is no substantive requirement forcing federal agencies to select a course of action
that an [environmental impact statement] identifies as environmentally preferable. The purpose of an
EIS is to inform agency decision making by identifying probable environmental impacts and making
this information . . . available for public scrutiny and debate.” Cole et al., supra note 318, at 1161
(internal citation omitted).
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assessment tools can be created and implemented, there needs to be a
careful empirical assessment that maps the ways in which race issues have
historically been treated within each agency, the existing mechanisms or
procedures (if any) used to examine the legitimacy of race specific claims,
and how existing or pending innovations in each field might interact with
current regulatory assessments. As a more qualitative assessment,
significant field work (such as interviews or focus groups with employees)
regarding organizational dynamics and existing procedures for discussing
race will help locate the opportunities and challenges associated with
institutionalizing an ethos of race sensitivity both within each agency and
across all relevant federal agencies.
These future projects need to be undertaken before robust race impact
assessment models can be developed. This Article reserves a more detailed
articulation of the substance and integration of race impact assessments
into administrative agencies until future research can lay the
aforementioned empirical groundwork. But for now, it is useful to briefly
sketch the work that race impact assessments might do. Take, for example,
a hypothetical new drug not unlike BiDil, where the manufacturer seeks a
race-specific indication for Latinos with renal disease based on impressive
clinical trial results with participants that self-identify as Latino. An FDAled race impact assessment might begin by identifying relevant
stakeholders to participate in not only analyzing the claims’ scientific merit
and clinical trial results, but also the impact that this particular race-specific
indication might have on racial minorities. This would be balanced with the
potential benefit produced by the race-specific indication, such as the
ability to identify and treat more Latinos suffering from this condition or to
increase compliance within this group. Multiple methods would be used to
evaluate the evidence—both the statistical assessment of clinical trial data
and the qualitative assessment of constituent perspectives. A final report
would be presented to FDA officials to aid their determination of whether a
race-specific indication is warranted for the drug.
The FTC might engage in a similar process to assess products
claiming to use genetic technologies to determine individuals’ racial
backgrounds. A diverse committee of experts—from population geneticists
to legal scholars and philosophers—in addition to laypersons would
examine the claims in relation to the strength and limitations of the
company’s methods and data. The committee would also collect and assess
qualitative data from affected stakeholders to analyze the ways this
technology might affect certain communities and how the public perceives

OBASOGIE FINAL V3

2012]

2/26/2013 1:33 PM

The Return of Biological Race?

63

the biological relevance of race. The committee would then provide a
report to FTC officials to inform their decision about how to oversee the
sale and marketing of these products.
The FBI could also use race impact assessments to examine the
implications of emerging forensic techniques that may disproportionately
affect minority communities. Not only would an external, quantitativelydriven scientific evaluation of techniques help assess whether the racebased or race-impacting methods are valid, but a qualitative assessment of
stakeholder sentiments might also help the FBI develop procedures that
both assist them in law enforcement and respect community concerns.
V. CONCLUSION
When the first draft of the human genome was completed in 2000 and
showed that all humans are 99.9 percent similar at the molecular level,333
scientists, politicians, and the media rejoiced in declaring that there are no
biological differences between racial groups, not unlike the way biological
race was publically discredited after World War II.334 President Bill
Clinton summed up the sentiment in a statement made from the East Room
of the White House when he pronounced that “modern science has
confirmed what we first learned from ancient fates. The most important
fact of life on this Earth is our common humanity.”335
However, just as biological race remained a salient, if not prominent,
variable in scientific research after the 1950 UNESCO statement publicly
declared its death,336 so too has it remained a powerful lens through which
we understand human difference in the genomic era. Rather than focusing
on our shared humanity, researchers have focused intensely on the less than
1 percent of genetic variation thought to explain racial difference and
disparities.
There may very well be important innovations emerging from this
renewed focus on biological race. But, given the horrific track record that

333. See Nicholas Wade, READING THE BOOK OF LIFE: Now, the Hard Part: Putting the
Genome to Work, N.Y. TIMES, June 27, 2000, at F1. Subsequent research has revised this figure to
around 99.5 percent. See generally, Samuel Levy et al., The Diploid Genome Sequence of an Individual
Human, 5 PLOS BIOLOGY 2113 (2007).
334. See supra Part II.C.
335. Bill Clinton, Pres. U.S., Tony Blair, P.M. Eng., Dr. Francis Collins, Dir. Nat’l Human
Genome Research Inst. & Dr. Craig Venter, Pres. & Chief Sci. Officer Celera Genomics Corp.,
Remarks on the Completion of the First Survey of the Entire Human Genome Project (June 26, 2000),
available at http://www.ornl.gov/sci/techresources/Human_Genome/project/clinton2.shtml.
336. See supra Part II.C.
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we have with using science to measure and define racial difference, the
government needs to take strong steps to ensure that these technologies are
used responsibly. Administrative agency race impact assessments are an
important first step to providing a democratic, deliberative, and
collaborative space to collect and analyze the data necessary to inform
decision makers on how to sensibly regulate these new innovations.

